Skip to content

Trading Analysis Report: CARR

  • Analysis date: 2026-10-14
  • Rating: Underweight
  • Generated: 2026-10-14 17:29:03
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports

Market Analyst

Current Price: 54.24 Price As Of: 2026-10-14

CARR (Carrier Global Corporation, NYQ): Technical Report as of 2026-10-14

1. Summary

CARR is in a confirmed downtrend on all three SuperTrend timeframes. For the last 3½ weeks it has been consolidating near its lows, and that consolidation is fading.

  • Trend: Price is below the 10 EMA, 50 SMA and 200 SMA, and all three SuperTrend tiers are DOWN.
  • Consolidation: Closes since the 2026-09-18 low have held between 53.88 and 56.37. Today's close of 54.24 sits at the bottom of that band.
  • Momentum: RSI is below 40 and the MACD histogram is shrinking.
  • Volume: OBV is at a new low for the window while price is not, which is a negative divergence.
  • Stretch: No Z-score is at ±2, so there is no statistical extreme to trade against.

The tools lean bearish to neutral. The nearest decision point is a break of the 53.88–53.94 area.

2. Indicators chosen and why

Role Indicator Why
Trend (multi-timeframe) supertrend Gives direction and a trailing-stop level on weekly, monthly and daily bars.
Trend strength adx Shows whether the consolidation is a range or the start of a trend.
Momentum rsi Shows overbought and oversold readings and whether the bounce is holding.
Momentum macdh Shows momentum shifts early.
Volatility atr Used for stop distance and position sizing.
Volume obv Checks whether volume confirms the price action.
Exhaustion td_9 Flags trend exhaustion across timeframes.
Stretch z_score Flags mean-reversion setups.

The 10 EMA, 50 SMA, 200 SMA and Bollinger bands come from the verified snapshot, so I didn't request them again.

3. Trend structure

Moving averages (verified snapshot): - 10 EMA is 55.21, 50 SMA is 58.08 and 200 SMA is 61.44. The close of 54.24 is below all three. - The averages are stacked bearishly (10 < 50 < 200). The 50 SMA is below the 200 SMA. - Price is about 11.7% below the 200 SMA, which I calculated from the verified 54.24 and 61.44. - The tools don't date when the 50/200 cross happened, so I'm not claiming a date.

SuperTrend (weekly carries the most weight): - Weekly: DOWN, stop at 66.98. The close is 19.03% below it. - Monthly: DOWN, stop at 75.97. The close is 28.61% below it. - Daily: DOWN, stop at 58.47. The close is 7.24% below it. - There is no timeframe conflict. A daily flip would need a close above 58.47. A weekly flip would need a close above 66.98.

Price structure from the OHLCV data: - The year's closing high was 75.73 on 2026-06-25. The close is now about 28% below that. - Closing highs have stepped down since then: 69.33 (07-27), 65.69 (08-04), 59.71 (09-04) and 56.37 (09-25). - Closing lows have stepped down too: 59.92 (07-29), 57.25 (09-01) and 53.88 (09-18). - The 07-28 and 07-29 sessions fell from 69.33 to 63.16 to 59.92 on about 16.4M and 16.6M shares. The tools don't identify the catalyst. - The 09-15 and 09-18 sessions traded 13.3M and 21.4M shares as price fell from 57.26 to 53.88. 09-18 was the third Friday of September. That may explain the volume, but it is my inference and the tools don't confirm it.

ADX is 15.79, below the 20 threshold: - It peaked at 36.80 on 2026-09-21 during the sell-off and fell to 11.14 on 10-12. - It is now ticking up (11.14 → 13.01 → 15.79) on a down day. - The market is range-bound for now. Trend-following signals are less reliable below 20, but the uptick on falling price deserves watching. - I didn't pull +DI and -DI, so I can't report which side is gaining.

4. Momentum

RSI is 37.69. - It was 27.14 on 09-18 (oversold) and recovered to a window high of 45.99 on 10-06. - It has not reached 50 at any point in the last 30 days, which is typical of a downtrend. It is now falling again from 41.58 yesterday.

MACD (snapshot): - The MACD line is -0.82 and the signal is -0.98, so both are below zero. - The histogram is +0.16. It turned positive on 09-23 and peaked at 0.343 on 10-06. - It has fallen four sessions in a row: 0.307, 0.286, 0.243, 0.162. - Another weak session or two would push it negative and give a bearish MACD cross. The bullish cross in late September produced little follow-through, as price only reached 56.37.

5. Volatility and Bollinger bands

  • Bollinger bands: the middle is 55.19, the upper is 56.45 and the lower is 53.94. The close is only 0.30 above the lower band.
  • ATR: 1.45, about 2.7% of price. It has contracted from 1.90 on 09-18, so the range is quieter.
  • Today's bar: open 54.18, high 54.65, low 53.58, close 54.24. It gapped down from the prior close of 55.03, a 1.4% decline for the day. It closed below both the 10 EMA and the Bollinger middle.
  • Stop distances: 1.5× ATR is about 2.2 points and 2× ATR is about 2.9 points.

6. Volume

  • OBV is -93.56M, the lowest reading in the 30-day window. It was -45.1M on 09-14.
  • Divergence: The 09-18 close of 53.88 was lower than today's 54.24, yet OBV was higher then (-81.9M) than now. Price has held above its low while OBV has made a new low, which points to distribution or weak buying.
  • Failed bounce: OBV peaked at -66.8M on 09-22 and -70.1M on 09-25, then rolled over.
  • Quiet consolidation: Over the last eight sessions volume has mostly been 3–5M shares. The high-volume sessions were the sell-off days, with no comparable volume on up days.

7. Exhaustion and stretch

TD-9: - Weekly -1, monthly +3, daily +1. No setup is near 9, so there is no exhaustion signal at any timeframe. - The monthly +3 is the furthest along but would need six more monthly bars.

Z-score (20-period): - Weekly -1.35, monthly -1.22, daily -1.52. - All three are below the mean but inside ±2. Price is somewhat extended to the downside, not at a statistical extreme, and the daily reading could still go lower.

8. Levels and scenarios

These come from the tools and the OHLCV history. They are reference levels, not validated support or resistance.

Upside reference levels: - 55.19–55.21: the Bollinger middle and the 10 EMA. - 56.37–56.45: the 09-25 close and the upper band. The 09-25 high was 56.79. - 58.08–58.47: the 50 SMA and the daily SuperTrend stop. - 61.44: the 200 SMA. - 66.98: the weekly SuperTrend stop.

Downside reference levels: - 53.88–53.94: the 09-18 closing low and the lower Bollinger band. - 52.96: the 09-18 intraday low. - 53.39 (2026-03-30) and 53.65 (2026-03-27) are earlier intraday lows in the same area. After the 03-30 close of 53.97, the next close was 55.91 on 03-31. - 51.34–51.43: the lows on 2025-12-17 and 2025-12-09. - 49.67–49.79: the intraday low on 2026-01-06 (49.67) and the closing low on 2025-11-20 (49.79).

Bearish scenario: - A close below about 53.9 on rising volume would break the multi-week floor. - A rising ADX above 20, a negative MACD histogram and OBV making further lows would confirm it. - The next levels are 52.96 and then the 51.3–51.4 area.

Relief scenario: - A close back above 55.2 would reclaim the 10 EMA and the Bollinger middle. - The next hurdle is 56.4–56.8. - A daily SuperTrend flip would need a close above 58.47, and the weekly and monthly trends would still be down. - Oversold support is limited. RSI is 37.69, not below 30, and no Z-score is at -2.

9. Data notes

  • The snapshot and the indicator tool agree on RSI (37.69), MACD histogram (0.16) and ATR (1.45). I found no discrepancies.
  • ADX, OBV, SuperTrend, TD-9 and Z-score come only from the indicator tool, because the snapshot doesn't include them.
  • The 10-14 volume of 4,611,812 is not rounded to the nearest hundred like the other rows. That may mean the bar isn't final, so check it before relying on today's volume or OBV.

10. Key points

Item Reading Interpretation
Close (2026-10-14) 54.24 Bottom of the 53.88–56.37 closing range since 09-18
10 EMA / 50 SMA / 200 SMA 55.21 / 58.08 / 61.44 Price below all three; bearish stack
SuperTrend weekly / monthly / daily DOWN (66.98 / 75.97 / 58.47) All timeframes bearish; weekly weighted most
ADX 15.79 (36.80 on 09-21) Range-bound, ticking up from 11.14; no confirmed trend
RSI 37.69 Bearish bias; capped at 45.99 in the last 30 days; not oversold
MACD / signal / histogram -0.82 / -0.98 / +0.16 Histogram positive but falling for four sessions; at risk of turning negative
Bollinger (lower / mid / upper) 53.94 / 55.19 / 56.45 Close 0.30 above the lower band
ATR 1.45 (about 2.7% of price) Down from 1.90 on 09-18; 2× ATR is about 2.9 points
OBV -93.56M (-45.1M on 09-14) Window low while price holds above its 09-18 low; negative divergence
TD-9 (W / M / D) -1 / +3 / +1 No exhaustion signal
Z-score (W / M / D) -1.35 / -1.22 / -1.52 Moderately below the mean; no ±2 extreme
Key downside levels 53.88–53.94, 52.96, 51.3–51.4, 49.7–49.8 Break of 53.9 on volume is the bearish trigger
Key upside levels 55.2, 56.4–56.8, 58.1–58.5, 61.44, 66.98 Reclaiming 55.2 is the first relief step
Net read Bearish to neutral Downtrend intact with a weakening base; no reversal signal

Sentiment Analyst

Overall Sentiment: Mildly Bearish (Score: 3.9/10) Confidence: Low

Scope and data limits. This report covers CARR (Carrier Global Corporation, NYSE) for 2026-10-07 to 2026-10-14. It rests on 9 news headlines (headlines and links only, no article bodies) and 9 StockTwits messages. The Reddit feed was disabled by configuration, so there is no Reddit read. No price, volume or options data is in the prompt, so I cannot say how far the stock moved on the downgrade. The headline says shares fell, but not by how much. Confidence is low because Reddit is missing, the StockTwits sample is tiny and mostly unlabeled, and the news is headline-only.

1) Source-by-source breakdown

News (Yahoo Finance, 9 items) is the clearest signal and leans bearish, driven by sell-side actions: - Goldman Sachs downgraded CARR to Neutral with a $61 price target. MT Newswires ran a separate item, 'Carrier Global Shares Fall After Goldman Sachs Downgrade'. Goldman's prior rating is not in the headlines. A StockTwits post from briefing.com says it was Buy, and a Seeking Alpha headline shared on StockTwits says Goldman downgraded Lennox and Carrier while upgrading Trane Technologies. - RBC cut its target to $72 from $82 (about -12%) but kept Outperform. This is a valuation or estimate trim, not a thesis break. - Bernstein cut its target to $64 from $78 (about -18%). The rating is not stated in the headline, so I cannot say whether it was also downgraded. - That makes three negative or lowered-target actions in one week, with the Bernstein cut the steepest. - Company-driven items are procedural: a Q3 2026 earnings advisory (PR Newswire), a Barchart Q3 preview, and a quarterly dividend declaration. The headlines give no date for the earnings release, no guidance, and no dividend amount. - A StockStory piece on HVAC and Water Systems stocks in Q2 and a The Fly roundup (Dell downgrade, Texas Roadhouse upgrade) are in the feed. Their bodies are not provided, so I cannot attribute a sentiment or any CARR-specific content to them.

StockTwits (9 most-recent messages) is thin and low-signal: - The labeled ratio is 1 Bullish, 0 Bearish, 8 unlabeled. With n=9 this ratio is not meaningful. - The one Bullish tag (@Beeshee, Oct 13: 'getting hot, need ac') is a casual remark. It reads as weather or product demand, not an investment thesis. - @ItsCarRamRod posted twice (Oct 13 and Oct 14), cheering the downgrades and calling the products 'overpriced junk'. These are unlabeled and sarcastic, with a bearish or schadenfreude tone. They are a consumer-affordability take, not fundamental analysis. - @briefingcom relayed the Goldman downgrade (Buy to Neutral, $61 target), which is factual news flow. - @KryptonResearch14 (about $TT) said Goldman upgraded Trane to Buy with a $565 target. It said Goldman's fiscal 2027 estimates for Trane are about 4% above consensus, and that backlogs at Trane and Johnson Controls are up roughly 50% on average this year on large-scale cooling demand. This is the only substantive fundamental content in the sample. It does not mention CARR, but it explains the relative-preference logic behind the same-day Goldman moves. - @togsonkaks (Oct 9) is the only trader-style, mildly constructive post. CARR 'just broke downtrend and starting to form a mini uptrend', entry at 54 with risk at 53. This predates the Goldman downgrade and shows no price data for Oct 14. - Three messages are off-topic or promotional: an app advertisement ($CARR/$SPY, @JayStrauss), a $MOD promotion that tags $VRT, $CARR and $TT (@Miha241), and a GMGMF buyout speculation post. These add no sentiment signal.

Reddit: disabled by configuration. There is no data and no inference about r/wallstreetbets, r/stocks or r/investing.

2) Cross-source divergences and alignments - Alignment: the retail posts that carry real content (the downgrade relays and the mocking posts) echo the institutional downgrade. Retail is reacting to the news, not leading it. - No meaningful divergence. The 1/0 labeled ratio would look bullish in isolation, but a single ambiguous tag does not offset three sell-side negatives. Treating it as a divergence would overstate it. - Mild tension: the Oct 9 breakout-trade post, with a $54 entry and $53 stop, came before the downgrade. If the stock has fallen since, that stop may be in play. This is unverifiable here because no price data was provided. - Opinion versus event: the downgrade and target cuts are events from institutions and carry more weight. The StockTwits posts are mostly opinion or noise and carry little.

3) Dominant narrative themes - Sell-side de-rating: a Goldman downgrade plus target cuts at Bernstein and RBC, all within the week and ahead of Q3 earnings. - Sector rotation within HVAC: Goldman upgraded Trane while downgrading Lennox and Carrier. The shared Trane message points to large-scale and data-center cooling backlog growth (Trane and Johnson Controls, about +50%) as the preferred exposure. By implication, CARR is seen as less levered to that theme than Trane, though the sources do not state this directly. - Valuation and affordability: the 'overpriced' sentiment is a retail-consumer framing, not an analyst argument. - Peer comparison: the $MOD post pitches Modine, spun off Oct 1, as a data-center cooling alternative and lists CARR as a peer, which reinforces the data-center cooling theme.

4) Catalysts and risks - Catalyst: the Q3 2026 earnings release (an earnings advisory is in the feed; the date is not stated in the headlines). Results and guidance will test whether lowered targets were too conservative or justified. - Catalyst: the dividend declaration provides some income support. Amount and yield are not in the data. - Risk: further target cuts or downgrades. Bernstein's cut was steeper (about -18%) than RBC's (about -12%). Goldman's $61 target is the only fully specified neutral anchor. The prompt gives no current price, so I cannot say how much upside or downside it implies. - Risk: continued rotation toward data-center cooling names (Trane, Johnson Controls, Vertiv, Modine) at the expense of residential and light-commercial HVAC exposure. - Risk: affordability and demand concerns that retail posts hint at. This is anecdotal. - Upside offset: RBC still rates CARR Outperform with a $72 target, which is well above the $61 Goldman target. Analyst opinion is split. - Data gaps: no price action, no earnings date, no guidance, no Reddit, and no article bodies.

5) Summary table

Signal Direction Source Supporting evidence
Goldman downgrade to Neutral, PT $61 Bearish News (MT Newswires) and StockTwits (@briefingcom) Prior rating reported as Buy; headline says shares fell; magnitude not given
RBC PT cut to $72 from $82 Mildly Bearish News (MT Newswires) About -12%; Outperform retained
Bernstein PT cut to $64 from $78 Bearish News (MT Newswires) About -18%; rating not stated
Goldman favors Trane (Buy, PT $565) over CARR and Lennox Bearish (relative) StockTwits (@KryptonResearch14) and Seeking Alpha link Trane and Johnson Controls backlogs up about 50% on large-scale cooling; CARR not mentioned in the post itself
Q3 2026 earnings advisory and preview Neutral (catalyst) News (PR Newswire, Barchart) Date and expectations not given in the headlines
Quarterly dividend declared Neutral to Mildly Bullish News (PR Newswire) Amount not in headline
Retail mocking of downgrades Bearish-leaning (low weight) StockTwits (@ItsCarRamRod, 2 posts) 'Overpriced junk' framing; unlabeled; consumer anecdote
Retail technical setup Mildly Bullish (low weight) StockTwits (@togsonkaks, Oct 9) 'Broke downtrend', entry 54, risk 53; predates the downgrade
Labeled ratio 1 Bull / 0 Bear (n=9) Uninformative StockTwits Only tag is a casual 'need ac' remark; 8 of 9 unlabeled
Promotional and off-topic posts Noise StockTwits (@JayStrauss, @Miha241, GMGMF post) App ad, $MOD pitch, buyout speculation
Reddit No data Reddit Disabled by configuration

Bottom line: Institutional news flow is clearly negative for CARR this week (a downgrade plus two target cuts), and retail chatter is thin, mostly unlabeled and largely echoes the downgrade. Net sentiment is Mildly Bearish, with low confidence given the thin sample and missing Reddit data. This is a sentiment signal only and should be weighed with fundamentals, price action and the upcoming earnings report, not read as a price call.

News Analyst

CARR (Carrier Global Corporation, NYSE) – News and Macro Report for 2026-10-07 to 2026-10-14

Data coverage

  • Worked: company news (headlines only, no article bodies), global news headlines, and Polymarket prediction markets.
  • Failed: every FRED call (fed funds, 10-year Treasury, CPI, unemployment, yield curve, VIX) returned DATA_UNAVAILABLE because the API key isn't set. I give no numeric values for those series. Macro color below comes from headlines and prediction markets only.
  • Missing: the headlines don't give CARR's share price, the earnings date, or the dividend amount. I haven't guessed any of them.

1. Company-specific: CARR

Sell-side revisions are one-directional

Firm Action Rating Price target
Goldman Sachs Downgrade to Neutral (from Buy) Neutral $61 (was $74, cut from $85 earlier in the window)
RBC Cut target Outperform (kept) $72 (from $82)
Bernstein Cut target Not stated $64 (from $78)
Deutsche Bank Cut target Hold (kept) $64 (from $71)
  • Every move was a cut or a downgrade, and I found no upgrades or target increases.
  • Goldman cut its target twice in about a month ($85 → $74 → $61) and then dropped the rating. MT Newswires reported that CARR shares fell on the downgrade.
  • Targets now cluster around $61–$72. Even the most bullish of the four, RBC, cut by about 12%.
  • The headlines don't state the reasons for the cuts. The macro backdrop below (higher rates, hurt housing, an energy shock) is a plausible explanation, but that is my inference, not something the sources say.

Upcoming catalysts

  • Q3 2026 earnings: Carrier issued an earnings advisory, and Barchart ran a "What to Expect" preview. The date and consensus figures aren't in the retrieved text, so check the PR Newswire advisory.
  • Dividend: The board declared its regular quarterly cash dividend. The amount isn't in the headline. This is routine and is not a sign of a cut.
  • Sector read-across: StockStory's "HVAC and Water Systems Stocks in Q2" piece and Zacks' coverage of Comfort Systems' 92% EPS surge point to strength in HVAC-related and commercial/data-center-adjacent names. Zacks also ran a piece asking whether CARR is outperforming other construction stocks this year. I only saw the headlines, so I can't say what they concluded.
  • Read-through: The strong sector fundamentals (Comfort Systems) sit alongside falling CARR targets. That suggests the analyst concern is about CARR's exposure (likely residential, rate-sensitive end markets) or valuation, not about the HVAC industry as a whole. This is an inference.

2. Macro and market backdrop

Rates are the dominant story

  • Inflation and yields: Yahoo Finance reports the "10-year Treasury yield rises following hot inflation data." I couldn't verify the CPI print or the yield level.
  • Global bond selloff: "Bond yields are surging worldwide," and France is described as being on the "ugly side." A BofA fund manager survey says investors won't rotate from stocks into bonds until yields reach about 5.9%. The headline doesn't say which yield that refers to.
  • Housing: Mortgage rates are at their highest in nearly three years, and there's discussion of "Is 8% next?" This is the most direct headwind for residential HVAC demand (new construction, replacement financing, and housing turnover).

Fed expectations

  • Fed pricing has flipped toward hikes. Polymarket, December 2026 meeting (resolves 2026-12-09):
  • Hike 25 bp: 78% (up 4 pp in a week, ~$869K volume)
  • No change: 20%
  • Cut of 25 bp or more: about 1% or less
  • Hike of 50 bp or more: 3%
  • No cuts in 2026: 97% (up 1.2 pp in a week, ~$8.9M volume, the deepest market in this set).
  • The Fed-hike markets have thinner volume (under $1M each) than the "no cuts" market, so treat the 78% as directional, not precise.
  • Implication for CARR: There is no relief from falling rates in sight, and the next move is priced as a hike. That is negative for housing-linked demand and for multiples on long-duration industrials.

Growth and recession risk

  • US recession by end-2026: 8% (up 1 pp in a week, ~$2.3M volume). The market doesn't see an imminent downturn, so the setup looks like stagflation-lite (sticky inflation, higher rates, no recession) more than a growth scare.
  • UK recession: 8% and Japan: 4%. Both are very thinly traded (volume under $16K), so I wouldn't rely on them.

Energy and geopolitics

  • Oil: One headline says oil fell to about $103 after Trump said the US won't attack Iran before the midterm elections. Another notes "tech slumps as oil prices rise." Oil above $100 is an input-cost and inflation risk, and it feeds the rate story above.
  • Iran: The market gives a 16% chance the US invades Iran before 2027 (very high volume, ~$74M, up 1 pp in a week). Mojtaba Khamenei is priced at 87% to be head of state at end-2026, and a leadership change is at 12%. The political "no attack before midterms" comment may cap near-term escalation, but the tail risk remains. Oil is the transmission channel.

Equity sentiment

  • BlackRock turned more bearish on stocks, and Yahoo ran a piece on "bubble-like stock valuations and debt crisis chatter."
  • Tech has been volatile: it slumped as oil rose, then rebounded as "AI trade jitters ease." Banks rose on JPMorgan and Goldman earnings while chip stocks fell.
  • Q3 earnings season has begun, so CARR will report into a market that is sensitive to guidance.
  • Gold: Barchart argues for loading up before 2027, noting gold "lost its glitter" this year. That is an opinion piece, not a data point.

3. Takeaways for traders

  1. Estimate and rating momentum is clearly negative. All four recent analyst actions were cuts. With Q3 earnings approaching, the setup is that expectations are being reset lower, which can make a "beat and hold guidance" outcome easier to clear. It can also mean the sell-side expects a guidance cut. I have no consensus data to settle this.
  2. Key risk to watch on the earnings call: residential HVAC volumes and destocking, pricing versus input costs (oil is above $100), 2027 guidance, and commentary on commercial, data-center, and aftermarket strength. Peers like Comfort Systems show strong commercial demand.
  3. Macro is a headwind, not a shock. Hot inflation, rising global yields, 3-year-high mortgage rates, and a hike priced for December all weigh on rate-sensitive building products. Recession odds are low at 8%, so the risk is multiple compression and a soft housing-linked business, not a demand collapse.
  4. Event risk: The next CPI print, the December FOMC (priced for a hike), Iran and oil headlines, and Q3 earnings from CARR and its peers (Trane, JCI, Lennox, and others) are the likely volatility triggers. I did not research the peer reports.
  5. What would change the picture:
  6. Bullish: a soft CPI print, a falling 10-year yield, or oil staying near or below $100 (these would pull hike odds down).
  7. Bearish: oil spiking on Iran, 10-year yields rising further, or a guidance cut.

Summary table

Category Key point Evidence / source Implication for CARR
Analyst actions Goldman downgraded to Neutral, PT $61 (from $74, earlier $85) MT Newswires Negative momentum; stock fell on the news
Analyst actions RBC PT $72 (from $82, Outperform); Bernstein PT $64 (from $78); Deutsche PT $64 (from $71, Hold) MT Newswires Targets cluster at $61–$72; reasons not stated
Earnings Q3 2026 advisory issued; date and consensus not in retrieved text PR Newswire, Barchart Main near-term catalyst; verify date
Dividend Regular quarterly dividend declared (amount not given) PR Newswire Routine; no cut signal
Sector HVAC peers strong (Comfort Systems EPS +92%) Zacks, StockStory (headlines only) Industry demand isn't the problem; CARR-specific or rate-driven concern likely (inference)
Rates Hot inflation data; 10-year yield rising; global yields surging Yahoo Finance headlines Headwind to valuation and housing-linked demand
Housing Mortgage rates at ~3-year high; "Is 8% next?" Yahoo Finance Negative for residential HVAC
Fed (Polymarket) Dec hike 25 bp: 78%; no change: 20%; cut: ~1%; no 2026 cuts: 97% Polymarket No easing relief; hike risk is priced
Recession (Polymarket) US recession by end-2026: 8% Polymarket Low odds; the risk is rate and multiple pressure
Energy / geopolitics Oil about $103; US invasion of Iran before 2027: 16% Yahoo Finance, Polymarket Input-cost and inflation risk; tail risk if tensions flare
Sentiment BlackRock more bearish; bubble-valuation worries; tech volatile Yahoo Finance Higher bar for earnings and guidance
Data gaps FRED macro series unavailable (no API key); no CARR price or earnings date Tool errors CPI, yield, and unemployment levels are unverified; don't rely on them

Fundamentals Analyst

CARR (Carrier Global Corporation) Fundamental Report

Industrials / Building Products & Equipment, NYSE. Analysis date: 2026-10-14.

0. Data caveats

  • The statement tools stop at 2026-03-31 (Q1 2026). No 2026-06-30 column appears in the income statement, balance sheet or cash flow, even though the Q2 10-Q should be on file by now.
  • The get_fundamentals snapshot appears to include Q2 2026. Its TTM revenue, net income and EPS don't reconcile to FY2025 plus Q1 2026. They reconcile if Q2 2026 is included (see §2).
  • Several Q4 columns are blank. I derived Q4 2025 as FY2025 minus the 9-month figures. The same method reproduces the reported Q4 2024 revenue ($5,148M) and operating income ($774M).
  • No debt, interest or gross profit lines are available in the statements. Leverage figures below are rough estimates from the D/E ratio.
  • Nothing in the data falls in the past week. The latest insider entry is 2026-07-01, and the statements end at 3/31/26.
  • Items marked (derived) or (inferred) are my calculations, not reported figures.

1. Snapshot and valuation

Metric Value
Market cap ~$45.05B
Implied price ~$54.2 (derived: P/B 3.40 × book value $15.935)
52-week range $50.24 – $76.76
50-day / 200-day average $58.31 / $61.70
P/E (TTM) 39.3x
Forward P/E 16.4x (forward EPS $3.31)
PEG 1.07
P/B 3.40x
Dividend yield 1.74%
Beta 1.29
ROE / ROA 8.97% / 2.98%
Profit margin / operating margin 5.5% / 13.1%
Gross margin ~24.7% (derived: $5.459B / $22.108B)
TTM revenue / EBITDA / net income $22.11B / $3.09B / $1.17B
Debt/equity 0.92x
Current ratio 1.02
FCF (per snapshot) $862M
  • Price is below both averages. It is about 7% under the 50-day and 12% under the 200-day. It is about 29% below the 52-week high and about 8% above the low.
  • The P/E gap is large. The TTM P/E is 39x against a 16.4x forward P/E, so the market is pricing a big earnings rebound. Forward EPS of $3.31 is roughly 2.4x TTM EPS of $1.38.
  • The two EPS figures may not be comparable. The forward number is probably an adjusted figure and the TTM number is GAAP. The data does not include the company's adjusted EPS, so the gap can't be reconciled here.
  • Rough enterprise value and leverage (derived, assumes debt ≈ 0.92 × equity ≈ $12.7B, less $1.4B cash):
  • Net debt is about $11B.
  • EV is about $56B, or about 18x EBITDA.
  • Net debt/EBITDA is about 3.5x.
  • This is an estimate, and the 10-Q is needed to confirm.

Annual ($M)

FY Revenue YoY Operating income Op margin Net income Diluted EPS
2018 18,914 3,637 19.2% n/a 3.16
2019 18,608 -1.6% 2,491 13.4% n/a 2.44
2020 17,456 -6.2% 3,083 17.7% n/a 2.25
2021 20,613 +18.1% 2,645 12.8% n/a 1.87
2022 17,288 -16.1% 3,984 23.0% 3,534 4.10
2023 18,951 +9.6% 2,160 11.4% 1,349 1.58
2024 22,486 +18.7% 2,646 11.8% 5,604 6.15
2025 21,747 -3.3% 2,172 10.0% 1,484 1.72
  • Growth is slow. The 2018–2025 revenue CAGR is only about 2.0%. The jumps and drops in 2021, 2022 and 2024 come from acquisitions and divestitures, including the Viessmann Climate Solutions deal.
  • GAAP profit is distorted by one-offs. 2022 and 2024 include large divestiture-related gains, so FY2024 EPS of $6.15 and FY2022 EPS of $4.10 are not run-rate. The tool data doesn't itemize these.
  • Operating margin has drifted down. It went from 11.8% in 2024 to 10.0% in 2025.

Recent quarters ($M)

Quarter Revenue YoY Op income Op margin Net income EPS
Q1'25 5,218 -3.7% 629 12.1% 412 0.47
Q2'25 6,113 +3.0% 903 14.8% 591 0.68
Q3'25 5,579 -6.8% 539 9.7% 428 0.50
Q4'25 (derived) ~4,837 ~-6.0% ~101 ~2.1% ~53 ~0.07
Q1'26 5,341 +2.4% 259 4.8% 238 0.28
  • Margins fell sharply in the last two reported quarters. Q1'26 revenue grew 2.4% year over year, but operating income fell about 59% (from $629M to $259M). EPS fell about 40% (from $0.47 to $0.28).
  • Q4'25 looks very weak on a GAAP basis. Derived operating income is about $101M and EPS about $0.07. This is likely affected by charges, but the tool data doesn't break them out.
  • Q2'26 can only be inferred. I backed it out of the TTM figures, assuming they roll forward from the Q1'26 base:
  • Revenue is about $6.35B, up about 4% year over year.
  • Net income is about $455M, down from $591M.
  • EPS is about $0.53, down from $0.68.
  • If this is right, earnings were still down year over year, though less than in Q1.

3. Balance sheet ($M)

Date Total assets Cash Current assets Current liabilities Total liabilities Equity
12/31/23 32,822 9,852 19,576 6,981 23,817 9,005
12/31/24 37,403 3,969 9,891 7,892 23,008 14,395
12/31/25 37,190 1,555 8,533 7,114 23,062 14,128
3/31/26 37,186 1,371 9,018 8,585 23,385 13,801
  • Cash has run down. It fell from $9.9B at the end of 2023, when it was built up before the Viessmann deal, to $1.4B at 3/31/26.
  • Liquidity is thin. The Q1'26 current ratio is about 1.05 (9,018 / 8,585), and the snapshot shows 1.02.
  • Equity is drifting down. It is down about $1.2B from the mid-2025 peak of $15.0B, consistent with capital returns.
  • Total liabilities are flat at about $23B. Roughly $4.7B of financing outflows in 2025 therefore did not clearly reduce liabilities. The data doesn't show how that outflow split between buybacks, dividends and debt paydown.
  • Goodwill and intangibles are not itemized. After Viessmann, they are likely a large share of the $37B in assets, so impairment risk is worth checking in the filings.

4. Cash flow ($M)

Annual

FY Operating CF Capex FCF (derived) Financing CF
2018 2,055 263 1,792 -2,627
2019 2,063 243 1,820 -1,982
2020 1,692 312 1,380 -681
2021 2,237 344 1,893 -1,562
2022 1,743 317 1,426 -2,931
2023 2,607 439 2,168 +4,612
2024 563 519 44 -4,636
2025 2,513 392 2,121 -4,672
  • FY2025 cash generation was strong. FCF of about $2.1B is about 143% of GAAP net income and about 4.7% of market cap.
  • FY2024 operating cash flow was unusually low ($563M), probably related to the divestiture and Viessmann year. The data doesn't say why.

Q1 seasonality

Quarter Operating CF Capex FCF (derived)
Q1'24 40 102 -62
Q1'25 483 63 +420
Q1'26 79 94 -15
  • Q1 is seasonally weak. Q1'26 operating cash flow was $79M against $483M a year earlier, but that is in line with the 2022–2024 pattern.
  • The FCF figures conflict.
  • The snapshot shows $862M.
  • My TTM through Q1'26 is about $1.69B (FY2025 less Q1'25 plus Q1'26).
  • The snapshot figure may use a different period or definition, or may reflect a weak Q2'26. Treat it with caution until the Q2 cash flow statement is checked.
  • Dividend coverage looks thin on the snapshot FCF. Estimated dividends are about $0.94/share × ~830M shares ≈ $780M (derived). That is only about 1.1x covered by $862M, but about 2.2x covered by the FY2025 FCF of $2.1B.

5. Insider activity

Date Insider Action Size
2026-05-20 M. Viessmann (Director, indirect) Sale @ $62.01 12,094,823 shares (~$750M)
2025-11-25 D. Gitlin (CEO) Open-market purchase @ $52.62 19,300 shares (~$1.02M)
2025-06-05 M. Viessmann (Director, indirect) Sale @ $70.30 4,267,425 shares (~$300M)
2025-02-14 K. Crockett (Officer) Sale @ $65.18 plus option exercise 18,945 sold (~$1.23M)
2024-11-06/07 K. O'Connor / K. Crockett Sales @ $73.46 / $76.34 plus option exercises ~$12.3M / ~$0.9M
Jan 2026 Gitlin, Goris and other officers Stock grants at $0 Gitlin 90,872; CFO Goris 40,750
Various (Feb–Jul 2026) Dryden, Pandya, Gierges, Heim Unlabeled "D" entries, no price 50 to 50,616 shares
  • Viessmann is a persistent seller. About 16.4M shares and about $1.05B have been sold across two blocks, at $70.30 and then $62.01. This is a falling-price pattern and a potential supply overhang. My background understanding is that the stake came from the Viessmann Climate Solutions deal, which isn't in the tool data. The remaining stake and any lock-up terms are not in the data.
  • The CEO bought at $52.62. It was the only open-market insider buy in the data, and the implied price now is within about 3% of that level. The size is small (about $1M), but it is a positive signal.
  • Most other entries are routine. The January grants look like annual awards, and the blank-text entries can't be classified as buys or sells from this data. Dryden's and Pandya's entries recur at the same times each year, which suggests scheduled items, but I can't confirm that.
  • No insider activity in the past week.

6. Takeaways for the trader

Supportive factors - Forward P/E is 16.4x, with a PEG near 1.1 if the earnings recovery materializes. - FY2025 FCF was about $2.1B, a roughly 4.7% yield on market cap. The dividend yield is 1.74%. - The CEO bought at $52.62, and price is near that level and about 8% above the 52-week low. - Q2'26 looks, by inference, like a modest sequential improvement in revenue and EPS.

Risk factors - GAAP earnings are deteriorating. Operating margin was ~2% in Q4'25 (derived) and 4.8% in Q1'26. Revenue growth is flat to low. - The forward EPS bar is high. The forward EPS of $3.31 sits against trailing GAAP of $1.38 and FY2025 GAAP of $1.72. Quarterly run-rate EPS is $0.28–$0.53. - Leverage and liquidity are tight. My rough estimate of net debt/EBITDA is 3.5x, cash is $1.4B and the current ratio is about 1.0. - Cash flow signals conflict. The snapshot FCF is $862M against the ~$1.7B TTM I derived and the $2.1B FY2025 figure. Dividend coverage is thin on the lower number. - Technicals are weak. Price is below both moving averages, and Viessmann selling is a recurring overhang.

What to check next 1. The Q2'26 10-Q and press release. These are missing from the statements, and I'm inferring Q2 from the TTM figures. 2. The reconciliation of GAAP to adjusted EPS, and what drove the Q4'25 and Q1'26 charges. 3. Debt, interest and goodwill detail, since the tools don't provide them. 4. Q3'26 earnings. Carrier has historically reported in late October, but the date isn't in the data, so verify it. 5. Any Form 4 or 13D/G filings showing Viessmann's remaining stake.

Overall fundamental read: mixed to cautious. Cash generation and the valuation on forward earnings are supportive, while recent GAAP profitability, leverage and insider-supply dynamics weigh against the stock. The buy/sell decision is left to the downstream agent.

7. Summary table

Category Key point Read
Valuation P/E 39.3x TTM, 16.4x forward; PEG 1.07; P/B 3.4x; ~$54 implied price Cheap only if the EPS rebound arrives
Price trend Below 50-day ($58.3) and 200-day ($61.7); 29% under the 52-week high Bearish technically
Revenue FY2025 $21.7B (-3.3%); Q1'26 +2.4% YoY; 2018–25 CAGR ~2% Low growth
Profitability FY25 op margin 10.0%; Q4'25 ~2%, Q1'26 4.8% Deteriorating
EPS FY25 $1.72; Q1'26 $0.28 (from $0.47); implied Q2'26 ~$0.53 Weak; forward $3.31 is a stretch
Cash flow FY25 FCF ~$2.1B; Q1'26 FCF ~-$15M; snapshot FCF $862M Strong annually but conflicting data
Balance sheet Cash $1.4B; equity $13.8B; current ratio ~1.0; D/E 0.92x Tight liquidity, moderate-to-high leverage
Leverage (derived) Net debt ~$11B; ~3.5x EBITDA Elevated; confirm with filings
Dividend 1.74% yield; ~1.1x covered by snapshot FCF Safe on FY25 FCF, thin on snapshot FCF
Insiders Viessmann sold ~$1.05B (May 2026 at $62.01, June 2025 at $70.30); CEO bought $1M at $52.62 (Nov 2025) Overhang plus one small positive signal
Past-week activity No insider activity; statement data ends 3/31/26 Data lag; verify Q2'26
Catalysts Q3'26 earnings (likely late Oct, verify); EPS reconciliation; further Viessmann sales Event risk both ways
Data quality No gross profit, debt or Q2'26 lines in the statements; Q4 columns derived Use derived figures cautiously

II. Research Team Decision

Bull Researcher

Bull Analyst: # Bull Case for CARR (Carrier Global, $54.24): Bad News Is Priced In, and the Setup Is Asymmetric

Let me start with what the bears will bring, because most of it is true. The trend is down on every timeframe, the sell-side cut estimates all week, and GAAP margins have been ugly. My argument is that the market has priced this in. At $54, we're paying a trough multiple for a business with a trough-quality earnings print.

1. Every analyst target is still above the current price

Goldman downgraded to Neutral, and RBC, Bernstein and Deutsche cut targets. Look at where the targets landed:

Firm Target Upside from $54.24
Goldman (Neutral) $61 ~12%
Bernstein $64 ~18%
Deutsche (Hold) $64 ~18%
RBC (Outperform) $72 ~33%

Even the downgrade implies upside. Neutral isn't Sell. Goldman's move also reads as a relative call: it upgraded Trane while downgrading Carrier and Lennox, on the data-center cooling backlog theme. It rotated within the group. It didn't say HVAC demand is breaking.

The cuts also came in a cluster before Q3 earnings. Goldman went $85 → $74 → $61 in about a month. When the sell-side capitulates into a print, the bar gets lower and "less bad than feared" gets easier to deliver.

2. Valuation and cash generation

  • Forward P/E is 16.4x on $3.31 of forward EPS, with a PEG of about 1.07.
  • FY2025 free cash flow was about $2.1B, roughly 143% of GAAP net income and a ~4.7% yield on the $45B market cap. The dividend yield is 1.74%.
  • The business has real earnings power. In Q2'25, operating margin was 14.8%. In Q1'25 it was 12.1%.

3. The earnings trajectory looks like a trough

The Q1'26 operating margin of 4.8% is the bear's best exhibit, and I won't pretend it's pretty. But look at the direction:

  • Revenue growth has turned positive: +2.4% in Q1'26, and about +4% in Q2'26 (my inference from TTM figures).
  • Inferred Q2'26 net income of about $455M is nearly double Q1's $238M, and EPS recovers from $0.28 to roughly $0.53.
  • A drop from 12% margins to under 5% on a revenue increase looks more like charges and one-offs than structural collapse. That's my read, not a reported fact, and Q3 has to confirm it.

4. Sector demand is strong

Comfort Systems posted a 92% EPS surge, and Trane and Johnson Controls report backlogs up around 50% on large-scale cooling. Nobody is saying HVAC demand has disappeared. The debate is about Carrier's mix and valuation, and that's a more fixable problem than an industry downturn.

5. Insiders, supply and sentiment

  • CEO Gitlin bought ~$1M of stock at $52.62 in November 2025. We're within 3% of that price.
  • Viessmann's selling is a known overhang. About 16.4M shares have been sold across two blocks. Supply overhangs are a technical problem, not a thesis problem. When they clear, the cap lifts.
  • Sentiment is washed out. The social score is 3.9/10, and retail is posting "overpriced junk." The sell-side is capitulating. Contrarians look for exactly this.

6. Technical setup and risk/reward

I'll concede the stock is in a downtrend. But:

  • RSI hit 27.14 on the 9/18 low, on 21.4M shares of climactic volume. In the 3½ weeks since, price has held above that low.
  • The $50–54 zone has been tested repeatedly: March 2026 ($53.39), December 2025 ($51.34), the 52-week low ($50.24), and the CEO's purchase.
  • ATR has contracted from 1.90 to 1.45, and volume has dried up to 3–5M shares a day.

Trade math: a 2× ATR stop (~$2.9) puts the stop near $51.3, just under the December lows. The upside targets are the 200 SMA at $61.44 and Goldman's $61. That's about $7 of reward for $2.9 of risk, or roughly 2.5:1, with a dividend paid while we wait.

Where I expect the bear to push

"The TTM P/E is 39x." That's GAAP against an adjusted forward number, so the comparison is apples to oranges. It's a fair question whether $3.31 is achievable, but Q3 guidance is where we get the answer, not the TTM multiple.

"Leverage is ~3.5x net debt/EBITDA and cash is $1.4B." That figure is my own estimate from the D/E ratio. It's on trough EBITDA, and FY2025 FCF of $2.1B services the debt comfortably. Liquidity is tight but not distressed.

"The Fed is priced to hike (78% for December)." Yes, and that's a multiple headwind. But it's now the consensus view, the stock is already down 28%, and recession odds are only 8%. The risk is multiple compression, not a demand collapse, and a lot of that compression has already happened.

"OBV is at a new low." That's the best technical point against me, and I'll concede it's real. It tells me to wait for confirmation, which is why I'd treat a close above $55.2 as the first step and a flip above $58.47 as the real one. It doesn't change the valuation.

What would prove me wrong

  • A decisive close below $53.88 on rising volume, then below $52.96.
  • A Q3 guidance cut that makes $3.31 unreachable.
  • Evidence that the Q1 margin collapse is structural, not one-time charges.
  • Further Viessmann block sales that keep capping rallies.

Questions for the bear

Where do you think the multiple should be if the Q1 margin drop is non-recurring? And if all four recent analyst targets sit above today's price, what exactly is the downside case that isn't already in a stock trading 28% off its highs? Bull Analyst: # Bull Rebuttal: I'll Concede the Payoff Math, Not the Probabilities

The bear's best three points were the burden of proof on $3.31, the cash-flow range, and gap risk. I'll concede what's right in them and then show what's left.

What I concede

1. My "2.5:1" was a stop-based construct. With gap risk, a repeat of the 7/28 move (-8.9%) takes the stock to ~$49.4, a ~$4.8 loss against ~$7.2 to the 200 SMA. That's ~1.5:1. The bear's $46 fundamental case is worse.

So the payoff is roughly symmetric: -15% to $46 or +13% to $61.44. This is a probability trade, not an asymmetric-payoff trade. With a flat middle outcome, the long makes money in expectation if a clean print is at least ~1.15x as likely as a guide-cut. That is the real question.

2. Cash flow is a range, not $2.1B. It's $0.9B to $2.1B (1.9% to 4.7% yield). Even the low figure covers the dividend ~1.1x. The Q2 cash flow statement is the missing piece.

3. Three weaker arguments I'm dropping. The sentiment sample (9 messages) is too thin to be a contrarian signal. The CEO's $1M buy is small and stale, so it's a price reference, not evidence. And targets aren't a floor.

4. I can't show the forward P/E at the high. The bounds are 22.9x ($75.73 / $3.31) if EPS never moved, and zero compression if EPS fell proportionally. Reality is in between, and I can't pin it down.

Evidence on probability the bear hasn't addressed

The snapshot's 13.1% operating margin. It can't be TTM GAAP. TTM revenue is $22.11B, so 13.1% implies ~$2.9B of operating income. Q3'25, Q4'25 and Q1'26 sum to ~$0.9B, so Q2'26 would need ~$2.0B, a 31% margin. Vendor snapshots typically report the most recent quarter. If that holds here, Q2'26 operating income was ~$830M, a margin of ~13%, after 2.1% and 4.8% in the prior two quarters. A margin that snaps back in one quarter reads as charges, not structural decay.

This is an inference. The tool doesn't label the field, so the 10-Q has to confirm it. One caveat I'll raise myself: inferred net income of $455M is only ~55% of that operating income, against 65% in Q2'25. Something below the operating line is heavier, probably interest or tax.

Cash conversion. FY25 operating cash flow was $2.5B against net income of $1.48B, and FCF was 143% of net income. That fits GAAP understating cash earnings through non-cash charges, though working capital could also contribute. It doesn't fit a business whose economics collapsed.

The balance sheet. Current liabilities rose $1.47B in Q1'26, but total liabilities rose only $0.32B. Non-current liabilities fell $1.15B. That looks like reclassification of ~$1.1B toward current, not new borrowing. The bear's "maturing debt" reading is probably right, but a ~$1.1B rollover against $1.7B to $2.1B of FCF and $3.1B of EBITDA is a refinancing task, not a solvency question.

The "spent buffer" framing also misses that the $9.9B cash pile was pre-funded for Viessmann, per the fundamentals report. In 2025 the company earned $1.5B and generated $2.1B of FCF. Equity fell only $267M and total assets were flat at ~$37B. The cash left through financing, not losses.

Comps. Today's $1.38 TTM EPS contains a $0.07 quarter and a $0.28 quarter. If Q3 and Q4'26 merely match the inferred Q2 at $0.53, TTM EPS is ~$1.87. That's still ~29x GAAP, which is not cheap, and the thesis lives on adjusted earnings. But 39x is partly an artifact of two trough quarters.

Where the bear overreaches

Viessmann as a ceiling. You say $61 to $62 is resistance because he sold there. After the $62.01 block on 5/20, the stock rose to $75.73 by 6/25, up 22% in five weeks. The two sales were ~11.5 months apart, which looks scheduled rather than opportunistic, though the tools don't show lock-up terms.

The gap argument. The 7/28 gap started from $69, near highs, when the multiple was at its richest. Tuesday, 7/28 is consistent with a Q2 print (the tools don't confirm it). If so, the Q2 weakness I'm leaning on was absorbed then. The stock's further ~9.5% slide from $59.92 happened without a company print, from downgrades and rates. Gap risk is real, but it's a different setup than the one at $69.

"Show me your unverified inputs." Your 15% EPS cut is also "illustrative." We both have an unverified scenario. The difference is I've named what would falsify mine.

The sector argument. The only evidence on why analysts cut is Goldman's relative call on data-center backlogs at Trane and JCI. Underperforming Trane isn't an absolute earnings decline. My thesis doesn't need a re-mix, only margins back to ~10% to 13%.

Macro. The 78% hike odds trade on $869K of volume, while the deeper market is "no cuts in 2026" at 97% ($8.9M). That's higher-for-longer, not a new shock. Recession odds are 8%, so the risk is the multiple, not demand.

OBV. You win on direction. But "all high-volume days were down days" is too strong: OBV rose 15.1M in the two sessions after 9/18 (-81.9M to -66.8M). It then gave back 26.8M, so that bounce failed, and I accept that. It argues for staging the entry, not for ignoring valuation.

How I'd express it

  • Starter position, sized to the gap case. Size it so a drop to ~$49.4 (-9%) is tolerable, not to a stop that gaps through.
  • Add on a close above $55.2 with OBV stabilizing, or after a print with a GAAP-to-adjusted bridge showing the Q4/Q1 charges are non-recurring.
  • Invalidation: a close below $53.88 on rising volume, or a Q3 with operating margin well below 10% and no credible bridge, or guidance that puts $3.31 out of reach.

Questions for the bear

  1. If Q2 operating margin really was ~13%, how is Q4/Q1 structural when the next quarter recovered?
  2. What's your probability for a guide-cut below $3.31, and what is it based on, given the sources don't say why targets were cut?
  3. Does the snapshot's $3.31 already reflect this week's revisions? If it does, your 19.3x is stale. If it doesn't, I'll concede it's closer to 17x to 19x today.

The payoff is symmetric and I won't claim otherwise. My edge is one piece of evidence on probability, a plan sized for the gap, and a set of conditions that would make me wrong. Bull Analyst: # Bull Closing: We've Narrowed This to Two Numbers

You've pushed me off most of my ground, and I'll say where you're right before saying where you overreach.

What I concede

  • The 13.1% field is weak evidence. It is unlabeled, and even on my reading (Q2 operating income ~$830M) it is down from $903M a year ago. "Snapped back" is measured from the trough, not from last year. H1'26 EPS of ~$0.81 against $1.15 is a 30% decline.
  • My "7/28 absorbed the Q2 weakness" line is dropped. I can't date the print, and your either/or is fair. What I can say is that the stock went from $69.33 to $54.24 (-21.8%). Whatever drove it, the multiple compressed.
  • Your margin table stands. At 10–13% margins, GAAP EPS is ~$1.69–$2.20. Reaching $3.31 needs about $1.10 a share of add-backs. That is the load-bearing assumption.
  • The Q1 cash flow isn't evidence for me. Operating cash flow fell almost dollar for dollar with operating income, though Q1 is noisy.
  • The tape says not to add yet. The close is 0.30 above the lower band, OBV is at a new low and the MACD histogram has fallen four sessions in a row.

Where you overreach

1. The add-backs aren't free-floating. TTM EBITDA of $3.09B against ~$1.7B of operating income implies D&A of roughly $1.3–1.4B (derived). Companies typically add back only acquisition amortization, not all depreciation, and these tools can't split the two. Even if only half of that is amortization, after-tax it is ~$0.55–0.60 a share. That is more than half of your $1.10 gap before any restructuring.

This also weakens your working-capital story. FY25 operating cash flow ($2.51B) exceeded net income ($1.48B) by ~$1.03B. D&A of ~$1.3B covers that gap with room to spare. If FY25 D&A looked like the TTM figure, working capital was a small drag, not a release. I'm withdrawing my "non-cash charges" explanation for the same reason: neither story is needed. FY25 FCF of $2.1B looks like earnings plus ordinary D&A, which makes it a cleaner number than either of us treated it. I still won't call a 3.8–4.7% FCF yield cheap. It only supports the dividend (~2.2x covered on FY25 FCF).

2. You repeated the mismatch you faulted me for. The "$0.83 a quarter is above any GAAP quarter in five" comparison sets an adjusted target against GAAP actuals. The right test is FY25 adjusted EPS against $3.31, and neither of us has it. The bridge size sets how steep the climb is:

Add-back per share TTM adjusted-equivalent Growth needed to reach $3.31
$1.10 ~$2.48 ~+33%
$1.50 ~$2.88 ~+15%

Each $0.40 of bridge moves the required growth by ~18 points. This table cuts against me at the low end, but it is why the print matters more than anything else on the screen.

3. Your probabilities aren't evidence, and your "cut" bucket isn't a −15% bucket. The four revisions arrived in one week during a rate spike. Goldman's stated logic, as relayed in the sources, is a relative call on data-center backlogs. The sources give no reasons for any of the cuts, so "analysts have seen their models" is as unverifiable as "targets track the multiple." That should lower my confidence, but it doesn't justify a 47% prior.

Your bucket ("guidance or consensus resets below what $3.31 requires") also lumps a 5% trim with a bridge together with a 15% guide-down. They would not trade alike. Break-even odds depend on the average loss in that bucket:

Avg. loss if "cut" Gain if clean Break-even clean:cut
−15% +13.3% 1.15
−12% +13.3% 0.90
−10% +13.3% 0.75

Your 0.47 loses in every row, so on your odds I'd wait too. My own estimate is ~0.8–1.0, which is also judgment. That puts the trade near break-even, not clearly positive. We're arguing about whether the odds are 0.47 or closer to 0.9, and nothing in the data settles that.

4. The refinancing cost is small. Suppose the ~$1.1B reclassified to current is debt and it rolls at a coupon 100–200bp higher. That is $11–22M pre-tax, or about $0.01–0.02 a share. It is a flexibility problem (no buybacks), not an EPS problem.

5. "Not a trough multiple" has no comparison. 18x EV/EBITDA (14x with your add-back) tells us nothing without peer multiples, and the data has none. We both rest on forward EPS, which brings us back to the bridge.

Where this leaves the trade

Your "what would move me" list and my add triggers are nearly the same: an itemized bridge, margin at 10–13% or better, guidance versus $3.31, the 10-Q confirming Q2, and a close above $58.47 with an OBV higher low. What we disagree on is whether a starter position before the print is worth its risk.

My view is that it is a small, honest bet. A starter of no more than a third of full size is defensible if it can absorb a gap to ~$49.4 (-9%). The rest waits for confirmation. If the mandate can't absorb a gap on any size, waiting is the better call, and I wouldn't argue with it.

Invalidation: a close below $53.88 on rising volume, a Q3 with margin well under 10% and no bridge, or guidance that puts $3.31 out of reach.

Questions for the bear

  1. What is FY25 adjusted EPS? If neither of us knows, is "$3.31 is a stretch" a conclusion or a conditional?
  2. How would you expect the stock to trade on a reset to ~$3.00 with a credible bridge and margin back above 10%? By your taxonomy that is a cut, but it isn't obviously a −15% day.
  3. Do you accept that the whole disagreement is clean-to-cut odds of 0.47 versus roughly 0.75–1.15, and that the print resolves it? Bull Analyst: # Bull Closing: The Print Decides It, and 45% Cut Odds Are Too High

You've narrowed this to a GAAP-to-adjusted bridge and the odds of a clean print, and I agree on both. I'll be brief on what I give up, then spend the rest on where your numbers are weaker than they look.

What I concede

  • It isn't asymmetric. Buying before the print is about zero EV at my odds (+0.3%) and negative at yours (-2.9%). I won't call it a bargain.
  • Your waiting math is right in structure. Buying now beats waiting only if P(clean) × the gap I'd miss exceeds P(cut) × the loss I'd eat, plus the small middle-bucket drag. At 35/35/30 and an 8-point clean gap, that requires a cut loss under ~8%. That is about 7/28's one-day move, not the 13.6% two-day move. At my odds, buying now is break-even at best.
  • $53.88 isn't protection. It's 0.66% under the close against a 2.7% ATR, and it does nothing against an earnings gap. Size is the only real risk control.
  • Q2 is public. I'm no longer treating a "recovering Q2" as a catalyst. It's the latest read on run-rate.

Where I still disagree

1. The revisions don't say what you say they say

Your 45% cut probability rests on the claim that analysts have seen what they put in their models. Check the targets against $3.31:

Target On $3.31 If EPS is cut 15% to $2.81
Goldman $61 18.4x 21.7x
Bernstein / Deutsche $64 19.3x 22.8x
RBC $72 21.8x 25.6x

An analyst who modeled your cut bucket would be paying 22–26x for a ~2% grower with ~3.5x leverage. These targets fit better with analysts trimming multiples for rates and rotation while keeping EPS nearer $3.31. Three of the four target cuts (-10%, -12%, -18%) are also smaller than the 21.8% the stock has fallen since 7/28.

This is not proof. I don't have the estimates, targets may sit on a different year's EPS, and Goldman's -28% includes a downgrade. But your reading of "four of four cuts" as evidence of EPS cuts isn't what the arithmetic favors. I'd put the cut bucket at 25–30%, not 45%.

2. The Q4/Q1 shortfall isn't volume, and Q4 isn't seasonally soft

You said Q4 and Q1 are seasonally soft, so the shortfall is overstated. In the one Q4 we can see, Q4'24, the margin was 15.0% ($774M on $5,148M). That's the figure you used to validate the derivation method. Applying each quarter's own prior-year margin (15.0% for Q4, 12.1% for Q1) gives a shortfall of ~$1.0B pre-tax, or ~$0.95 a share after tax at your 22% rate and 830M shares. That's slightly larger than your $0.90.

Volume doesn't explain it:

  • Q4'25: Revenue fell ~$311M and operating income fell $673M. Even at a generous 40% decremental margin, volume explains ~$125M.
  • Q1'26: Revenue rose ~$123M while operating income fell $370M. That's ~$420M unexplained.

Together that's roughly $0.95B of operating income decline that isn't volume. The alternatives are discrete items (my read) or a price/cost/mix break, which the tools can't exclude. But a break that size would have to be mostly gone by Q2. Q2 net income of ~$455M is derived from the TTM figures, not the unlabeled margin field, and you accepted it. It's 1.9x Q1 and 8.6x Q4. Whatever Q2 was, it wasn't a third trough quarter. It was still -23% year over year, so this is recovery from a trough, not a full recovery.

So I'd weight your +15% to +25% rows more heavily than your +30–35% "middle." The decisive check is a 30-second lookup: FY25 adjusted EPS. At $2.88 or higher, $3.31 needs ≤15% growth. At $2.43 or lower, it needs ≥36%. That one number tells us which row we're in.

3. The decision is closer than either table suggests

Take my 0.8–1.0 clean-to-cut odds and a 9–13% cut gap. The difference between buying now and waiting then falls within roughly ±1.5 points. That's smaller than the error bar on the odds themselves, so it's a sizing question, not a thesis question.

How I'd run it

  • Before the print: at most a third of intended size, and only if the mandate can absorb -13%, not -9%. If it can't, wait. I wouldn't argue with that.
  • Add on the print if it shows an itemized bridge of roughly $1.10–1.50 a share, Q3 operating margin at or above 9.7%, and guidance near $3.3 (or a reset to ~$3.00 with that bridge). A close above $58.47 with an OBV higher low is the tape confirmation.
  • Invalidation is event-based, not a price stop: Q3 margin below 9.7% with no itemized bridge, or guidance implying EPS well under $3.00 with no bridge. I'd treat a post-print close below the January low ($49.67) as the thesis break.

The bull case in one paragraph

CARR is not cheap on trailing numbers, and I'm not claiming it is. The case is narrower. The forward multiple is 16.4x, and the gap to $3.31 is mostly a question of whether ~$0.95 a share of Q4/Q1 shortfall was discrete, which the volume math favors. FY25 FCF covers the dividend ~2.2x. The sector's commercial demand is strong. The stock has spent 3½ weeks stabilizing after a climactic 21.4M-share flush at RSI 27. If the print supplies a bridge, this is likely a better entry than today's. If it doesn't, I lose a few points and will say the thesis was wrong.

Two questions for the bear

  1. If FY25 adjusted EPS is $2.88 or higher, do you agree your cut bucket should shrink and the +15% row becomes the central case?
  2. What explains ~$0.95B of operating income decline on revenue moves of -6% and +2.4%, other than discrete items or a price/cost break that had largely faded by Q2? Bull Analyst: # Bull Close: The Disagreement Is Now Seven Points of Odds and Two Lookups

The bear and I agree on the structure. A bridge from GAAP to $3.31 and the clean-to-cut odds decide this, and the print resolves both. I'll give back what's earned, then show where the final table is weaker than it looks.

What I concede

  • Q3 margin ≥9.7% is a soft hurdle. It's a flat-year-over-year test. The itemized bridge and the guide are the real ones.
  • The FY25 adjusted EPS lookup isn't enough. It only settles the question if $3.31 is a next-fiscal-year number. If it's FY26, H1'26 is already banked, and even in the best row H2 needs roughly +30%. I can't confirm the vendor's convention, so the second lookup is which year $3.31 belongs to.
  • My invalidation levels don't protect against a gap. Size is the only protection.
  • The behavioral point is fair. Holding shares biases you toward calling a "reset to ~$3.00" a clean print. The fix is to write the bucket definitions down before the print, which I do below.
  • One clean print probably doesn't reach $61.44. The 200 SMA is a stretch target for a single event.
  • A correction to my own number. I repeated "~2.2x dividend coverage" from the fundamentals report. $2.12B / ~$780M is about 2.7x. The snapshot FCF of $862M still gives only ~1.1x.

Where the final table is off

1. The re-rating objection doesn't separate buying now from waiting. Using the bear's buckets, with G as the first-day clean gap, L as the cut loss and P as the bucket probabilities:

Buy now − Wait = P(clean) × G − P(middle) × 1 − P(cut) × L

The target drops out, as long as it sits above the gap. A smaller re-rating shrinks the absolute return for both the buyer and the waiter. It's an argument about whether to own the stock at all, not about timing.

"Clean is the status quo the price already reflects" also has a logic problem. Today's 16.4x is a probability-weighted blend of the three outcomes. If the middle and cut outcomes trade below 16.4x, the clean outcome has to trade above it, or the blend wouldn't equal today's price. Treating clean as unchanged assumes the price already equals the best case. That's the claim that needs proof.

2. The table mixes windows. The clean gap is +8%, which mirrors 7/28's one-day move (−8.9%). The cut loss is −13%, which is the two-day move (−13.6%). Applied symmetrically:

Treatment Gap / loss Buy − Wait at 35/35/30
One-day both ways +8 / −8.9 ≈ −0.2
Two-day both ways +13 / −13.6 ≈ +0.1
Bear's mix +8 / −13 −1.45

The bear's own confirmation entry also costs more than 8 points. A close above 58.47 is +7.8%, and an OBV higher low takes more sessions on top of that. A waiter who waits for the stated triggers is likely buying 10–12 points higher, where the difference runs from about −0.75 to roughly zero.

I'm not claiming buying now wins. I'm claiming that "the sign favors waiting at every odds set" depends on an asymmetric assumption. With symmetric windows, the difference is within noise at my odds. The bear's break-even of roughly 1.6–1.8 clean-to-cut is real if the loss runs 13 points and the gap is 8, but it falls toward 1.0 as those converge.

3. The oil and input-cost candidate can be tested. The bear offers input costs (oil near $103, hot inflation) as a non-one-off driver. A price/cost squeeze shows up in gross margin. A discrete charge shows up below the gross line, in restructuring, impairment or other items. The statements here don't split gross profit by quarter, but Q1'26 vs. Q1'25 gross margin is a quick lookup that separates the bear's candidate from mine.

Where I land

The cut-probability gap is now ~28% (mine) vs. ~35% (the bear's revised figure). The sources can't resolve a 7-point difference, and the EV difference between buying now and waiting is within about ±1.5 points, smaller than the error bars on either set of odds. So I'm not claiming an edge before the print.

Before the print: - A starter of at most a third of full size, and only if the mandate can absorb a ~−13% gap. If it can't, wait. That's a legitimate call, and I won't argue against it.

Pre-registered buckets (written now, applied after): - Clean (add): an itemized bridge totaling ~$1.10–1.50/share, a named and sized Q4/Q1 charge, guidance near $3.3, and margin at or above 9.7%. - Middle (hold, no add): a reset to ~$3.00 with a bridge. I won't relabel it as clean. - Cut (exit): no bridge, margin under 10%, or guidance implying EPS well under $3.00. A post-print close below the January low ($49.67) is the thesis break.

The thesis in short: CARR isn't cheap on trailing numbers, and I'm not claiming it is. The case is that ~$0.95B of operating income decline isn't explained by volume (Q4 revenue -$311M against operating income -$673M, Q1 revenue up while operating income fell $370M). Q2 net income of ~$455M, 1.9x Q1, suggests it was a trough. Sector demand is strong and FCF covers the dividend. The stock has also spent 3½ weeks stabilizing after a climactic flush. If those charges are discrete and the bridge shows it, today's price is likely a better entry than the one the tape offers after the gap. If the bridge doesn't show it, I'm wrong and will say so.

Three lookups would settle most of this before the print: FY25 adjusted EPS, the fiscal year $3.31 refers to, and Q1'26 gross margin vs. a year ago.

Bear Researcher

Bear Analyst: # Bear Case for CARR ($54.24): "Priced In" Is an Assumption, Not a Fact

You opened by conceding the downtrend, the margin collapse and the estimate cuts, then argued the market has priced all of it in. That only works if you know what earnings will be, and your own numbers say we don't. The thesis rests on three unverified inputs: $3.31 of forward EPS, a "one-off" Q1, and strong cash flow. The verified data points the other way on all three.

1. This is not a trough multiple

The reported multiples are 39.3x TTM P/E, 3.4x book, and about 18x EV/EBITDA (derived, so approximate). ROE is about 9% and the 2018–2025 revenue CAGR is about 2%. The only cheap number is the 16.4x forward P/E, and it requires EPS to go from $1.38 TTM to $3.31, a 2.4x jump.

  • The best GAAP quarter in the last five was $0.68 (Q2'25, a seasonal peak). Annualized, that is $2.72, still short of $3.31.
  • Inferred H1'26 EPS is $0.28 + $0.53 = $0.81.
  • You call GAAP vs. adjusted "apples to oranges." Fair, but then you owe us the bridge, and the data doesn't have one. A $1.60 gap between FY25 GAAP ($1.72) and forward EPS ($3.31) is a lot of "adjustments." If charges hit in Q4'25 (~2% operating margin, derived) and again in Q1'26 (4.8%), they look like a pattern, not a one-off.
  • The denominator is also moving. Goldman cut its target 28% in a month ($85→$61), Bernstein 18%, RBC 12% and Deutsche 10%. Either estimates or multiples are being cut. Both hurt a 16.4x multiple built on a number analysts are lowering.

2. The "one-off" Q1 has a burden of proof you haven't met

Operating margin ran 14.8% in Q2'25, 9.7% in Q3'25, about 2.1% in Q4'25 (derived) and 4.8% in Q1'26. FY25 was 10.0% against 11.8% in FY24.

  • Your "real earnings power" of 12–15% comes from Q1'25 and Q2'25, the seasonally strongest quarters. The full-year figure was 10%.
  • Revenue rose 2.4% in Q1'26 while operating income fell 59%. You read that as charges. I read it as proof the problem isn't volume, so a volume recovery won't fix it. The data doesn't say which of us is right, and you admitted it is "my read, not a reported fact."
  • Even your "recovery" quarter is inferred, and it is still down year over year: net income of about $455M vs. $591M (-23%), EPS of $0.53 vs. $0.68. That is a smaller decline, not earnings power of $3.31. Q4'25 is also a $53M-net-income comp, so Q4'26 growth will look spectacular by arithmetic alone.

3. Sector strength is my argument, not yours

If Comfort Systems is up 92%, Trane and Johnson Controls backlogs are up ~50%, and CARR still gets downgraded with targets slashed, the problem is CARR-specific. Goldman rotated into Trane and out of CARR. There is no industry tide to wait for.

You call this "more fixable." Carrier can't re-mix a $22B business by Q3. The sources don't say why the analysts cut, so the exposure story is inference. But the macro leans against rate-sensitive HVAC: mortgage rates are at ~3-year highs, inflation ran hot, and the Fed hike odds are 78%, up 4 points in a week. That is a market still repricing, not a settled consensus.

You say "a lot of compression has already happened." Show me the forward P/E at the $75.73 high. If forward EPS fell as much as price, the multiple hasn't compressed at all.

4. You picked the best cash-flow number

Measure FCF Yield on $45B
Snapshot $862M 1.9%
TTM through Q1'26 (derived) ~$1.69B 3.8%
FY2025 $2.12B 4.7%
FY2024 $44M ~0%

You quoted the top line. The dividend (~$780M) is only about 1.1x covered by the snapshot figure.

The bigger problem is where the money went. In 2025, $4.7B left through financing against $2.1B of FCF, and the gap came out of the cash pile ($3.97B to $1.56B, now $1.37B, down from $9.9B at YE23). That buffer is spent.

  • The current ratio went from 1.25 to 1.20 to 1.05 in 15 months.
  • Current liabilities jumped $1.47B in Q1'26 alone while cash fell. The statements don't itemize it. If it is maturing debt, it refinances into a hike-priced market.
  • Net debt/EBITDA of ~3.5x is an estimate. Calling it "trough EBITDA" assumes the conclusion.
  • Post-Viessmann goodwill isn't itemized, so impairment risk is unquantified.

5. Insiders and sentiment

  • The CEO's buy: It was $1M, in November 2025, before the Q4'25 and Q1'26 margin collapses. It is the only open-market buy in the data. Viessmann sold ~$1.05B, roughly 1,000x as much.
  • Viessmann's sales: Viessmann is a director, selling with a board seat's information: $70.30, then $62.01, with each block lower. You call it a "known overhang," but the remaining stake and any lock-up terms are not in the data. An overhang of unknown size has no end date, so it isn't a catalyst. Also, $61–62 (Goldman's target and the 200 SMA) is exactly where Viessmann sold.
  • Sentiment: Your "washed out" read rests on 9 StockTwits messages, 8 unlabeled and 3 promotional, with confidence rated "low." That isn't a contrarian signal.
  • Your own contradiction: You say all targets are above the price (bullish) and the sell-side is capitulating (bullish). They can't both hold. Capitulation looks like Sell ratings and targets below the price. We have Outperform, Hold and Neutral, so there is room to cut further. Targets were also above the price at $70 and $60 on the way down, so they are not a floor.

6. The technicals and the "2.5:1"

  • "Held above the low" means $0.36 (0.7%) above the 9/18 close, and $0.30 above the lower Bollinger band. RSI peaked at 45.99 and never reached 50. The MACD histogram has fallen four sessions straight. ADX rose from 11.1 to 15.8 on a down day. OBV is at -93.6M, lower than at the 9/18 low (-81.9M) while price is higher. The high-volume days were all down days.
  • You concede OBV says wait for confirmation, then recommend buying at $54.24 before it.
  • A 2× ATR stop assumes continuous trading, and Q3 earnings is a gap event. On 7/28 the stock fell 8.9% in one session, and 13.6% over two (69.33→59.92) on 16M+ shares. The tools don't name the catalyst, but a repeat from here lands near $49.4, below your stop and the January low of $49.67. That is a ~$4.8 loss, so reward/risk is about 1.4:1 before probabilities. The path to $7 of upside also runs through 55.2, 56.4–56.8, 58.1–58.5 and the Viessmann zone.

Your questions

Where should the multiple be if Q1 is non-recurring? At the FY24–25 margin range of 10–12%, you have a ~2%-growth, ~9% ROE business with ~3.5x leverage. That deserves a market multiple, not a re-rating. A re-rating needs margins above where they were in FY24–25, and nobody has shown that.

What's the downside case? Q3 guidance implies a path below $3.31. Take an illustrative 15%, in line with the target cuts. EPS becomes ~$2.81, so today's price is already 19.3x. At an unchanged 16.4x, the stock is worth ~$46, about 15% lower and through the January low. That needs no multiple compression and no recession.

What would change my mind

  • A Q3 print with a GAAP-to-adjusted bridge showing the Q4/Q1 charges are non-recurring.
  • A credible, reaffirmed path to $3.31.
  • Operating margin back to 10% or higher.
  • OBV making a higher low, and a daily close above 58.47.

Until then, buying ahead of the print is paying for the "if." The setup is not asymmetric. Bear Analyst: # Bear Rebuttal: Agreed, It's a Probability Trade, and the Probabilities Favor Waiting

You dropped the 2.5:1 payoff, the sentiment read, the insider-buy argument and the target-floor argument. You also accepted that the long needs clean-print odds of at least 1.15x guide-cut odds. I'll fight on that ground, after giving back what you earned.

What I concede

  • Viessmann as a ceiling. The stock rose 22% after the $62.01 block, and sales ~11.5 months apart look scheduled. I'm downgrading this from "ceiling" to "remaining stake unquantified." If the cadence is annual, the next block is a 2027 issue, not a Q3 one.
  • OBV. "All high-volume days were down days" was too strong, since OBV gained 15.1M after 9/18. What stands is that OBV is -93.6M now versus -81.9M at the low, while price is higher.
  • Balance sheet. Your reclassification reading is better than mine. Current liabilities rose $1.47B, total liabilities only $0.32B, and non-current liabilities fell $1.15B. That is a refinancing, not a solvency problem. Cash also left through financing, not losses.
  • What survives. Cash is $1.37B against a ~$1.1B near-term maturity (if it is debt) and a ~$780M dividend. The refinancing happens with the Fed's next move priced as a hike. That is a no-flexibility problem: no buyback capacity, and any higher coupon hits EPS.

Your one piece of probability evidence

The arithmetic on the 13.1% operating margin checks out. I still have three problems with it.

  1. It's one unlabeled field. The snapshot's 5.5% profit margin is near TTM (NI $1.17B / revenue $22.11B = 5.3%). It is not near the 7.2% a Q2-only margin would be ($455M / $6.35B). So the snapshot mixes bases or the field means something else. A most-recent-quarter reading is plausible, but you called it "an inference" yourself.
  2. Granted, it's still down year over year. Operating income of ~$830M compares with $903M a year ago, on revenue up ~4%. The margin is 13.1% against 14.8%, net income is -23%, and inferred H1'26 EPS is $0.81 against $1.15 (-30%). "Snapped back" is measured from the trough, not from last year.
  3. Your inferences collide. Either 7/28 wasn't the Q2 print, in which case your "weakness was absorbed" argument has no event behind it. Or it was, and the stock fell 13.6% in two sessions on a print showing margin recovery. That means the market was reading something other than the margin: guidance, volumes, the forward number. Guidance is your own invalidation trigger. The stock then lost another 9.5% with no print at all, so the multiple is still compressing.

Margins of 10–13% don't get you to $3.31

You said the thesis only needs margins back to ~10–13%. FY25 at 10.0% earned $1.72 GAAP. Using the ~65% operating-to-net conversion from Q1'25 and Q2'25 (FY25 was 68%), ~850M shares and $22.1B of revenue:

Operating margin GAAP EPS (derived)
10% ~$1.69
13% ~$2.20
15% ~$2.54
~19–20% ~$3.31

At your own 13%, the remaining ~$1.10 per share is about $0.9B a year of after-tax add-backs. Amortization and restructuring may explain part of it, and TTM EBITDA of $3.09B against ~$1.7B of operating income implies large D&A. But nobody has itemized it, and it is the load-bearing assumption.

A definition-proof check is EV/EBITDA, which is ~18x (derived, assuming debt ≈ 0.92× equity). If I generously add back the entire excess Q4/Q1 charge (~$0.96B versus a 13% margin, which overstates it because those quarters are seasonally soft), it is still ~14x. That is not a trough multiple for a ~2% grower with ~3.5x leverage.

Cash conversion

FY25 operating cash flow above net income is fair, but a working-capital release in a year when revenue fell 3.3% fits equally well, and it reverses as revenue grows. In Q1'26, operating income fell $370M year over year and operating cash flow fell $404M, nearly dollar for dollar. That isn't what a mostly non-cash charge looks like. Q1 cash flow is noisy (Q1'24 was $40M), so I won't lean on it, but it doesn't support your reading either.

Your three questions

1. If Q2 recovered, how are Q4/Q1 structural? I'm not claiming they are. I'm claiming they're unproven and priced as fully non-recurring. Operating margin was already sliding from 11.8% to 10.0% before two consecutive quarters with up to ~$1B of shortfall. That is a pattern until a GAAP-to-adjusted bridge says otherwise, and the print is where the bridge arrives.

2. My probability of a guide-cut. This is judgment, not measurement: ~45–50% that guidance or consensus resets below what $3.31 requires, ~30% in-line, ~20–25% clearly clean. The sources don't say why targets were cut, but the revisions are the only independent evidence on the table: four of four are cuts, none are upgrades, and Goldman cut twice before downgrading. You read cuts into a print as a lower bar. I read them as analysts having seen what they're putting in their models. Neither of us can prove it, but the evidence points one way. That puts clean-to-cut odds near 0.5 against your 1.15 break-even.

3. Is $3.31 stale? I can't tell. If it is stale, we agree the forward P/E is closer to 17–19x. If it is fresh, it already contains the cuts and still needs ~$0.83 a quarter. That is 57% above your best inferred recent quarter ($0.53) and above any GAAP quarter in the last five (peak $0.68).

The trade

Every add and invalidation condition you listed is observable at the Q3 print: the bridge, margin versus 10%, and guidance versus $3.31. The date isn't in the data, but late October is the historical pattern. Buying now means paying to be early in a downtrend. The close is 0.30 above the lower Bollinger band, the MACD histogram has fallen four sessions straight, OBV is at a new low and hike odds are 78%. Your only probability edge is one disputed field.

If the print is clean, waiting costs part of the gap. If it's a cut, waiting avoids 9–15%. At break-even odds of 1.15 and a prior closer to 0.5, waiting wins. Sizing the starter for the gap case limits the damage, but it doesn't create an edge.

What would move me

  • A print with an itemized bridge showing the Q4/Q1 charges are non-recurring and the add-backs to $3.31 are roughly $1 per share of non-cash items.
  • Reaffirmed or raised guidance with margin holding at 10–13% or better.
  • The Q2 10-Q confirming the ~13% quarterly margin and clean free cash flow.
  • A close above 58.47 with OBV making a higher low.

Until the print supplies any of that, the burden sits with the long, and the revisions are the only independent evidence either of us has. Bear Analyst: # Bear Closing: I Accept the Framing, and It's the Case for Waiting

We now agree on what the debate is about: a bridge from GAAP to $3.31, and clean-to-cut odds the print will settle. The remaining question is whether to pay for that outcome before it arrives.

What I concede

  • My "$0.83 a quarter vs. GAAP" comparison was apples to oranges. The test is adjusted-to-adjusted, and neither of us has FY25 adjusted EPS. I'm withdrawing it.
  • Refinancing is not an EPS issue. 100–200bp on ~$1.1B is $0.01–0.02 a share, and we don't know that the reclassified amount is debt. It stays as a flexibility point only.
  • "Not a trough multiple" has no peer comparison behind it. "Trough" has none either. Both claims reduce to forward EPS.
  • Cash flow reads cleaner than either of us treated it. FY25 FCF of $2.12B is close to GAAP net income plus ~$1.3B of D&A less $0.39B of capex (~$2.4B). It supports the dividend. It does not show hidden earnings power.
  • My 0.47 was a poorly built bucket. A 5% trim with a bridge shouldn't be scored like a 15% guide-down. I'll re-bucket below.

Your best bridge row is the ceiling

Your table says a $1.10–1.50 bridge means +15% to +33% growth to reach $3.31. Here is what each row requires, using ~830M shares (market cap divided by price) and an assumed 22% tax rate:

Bridge/share What has to be true TTM adj.-equivalent Growth to $3.31
~$0.60 Amortization only (half of D&A). The Q4/Q1 shortfall is real. ~$1.98 ~+67%
~$1.05 Amortization plus half the Q4/Q1 shortfall as charges ~$2.43 ~+36%
~$1.50 Amortization plus all of the Q4/Q1 shortfall as charges ~$2.88 ~+15%

The Q4/Q1 shortfall versus a 13% margin is ~$0.96B pre-tax, or ~$0.90 a share after tax. Your +15% row therefore needs every dollar of that shortfall to be excluded charges. The 13% benchmark is the disputed field, and Q4 and Q1 are seasonally soft, so it overstates the shortfall. That row is the best case, not the middle. The middle is closer to +30–35% growth on a business growing revenue 2–4%. The forward EPS horizon (next fiscal year or next twelve months) isn't labeled in the data either, which helps you on time but costs you on certainty.

Your three questions

1. Is "$3.31 is a stretch" a conclusion or a conditional? It's a conditional. But the price already treats it as a fact, and the table shows what the condition is: the Q4/Q1 charges must be large and fully non-recurring. That is exactly what we can't verify today.

2. What does a reset to ~$3.00 with a credible bridge do? Mechanically, $3.00 × 16.4x is ~$49 (-9%). With a credible bridge and margin above 10%, I'd expect the multiple to hold or expand, so something like -5% to +3%. It isn't a -15% day, and I now count it as the middle bucket. One caveat: a beat against lowered Q3 consensus doesn't validate $3.31. The valuation rests on the forward number, which is what's being cut.

3. Is the whole disagreement 0.47 vs. 0.75–1.15, resolved by the print? Yes. That is my argument for waiting, because the resolution arrives soon. The date isn't in the data, but Carrier has historically reported in late October, about two weeks out.

Buying first vs. waiting

Three buckets, with judgment-based odds for both of us:

Outcome Stock move My odds Your odds (~0.9 clean:cut)
Clean: bridge itemized, margin ≥ prior-year 9.7%, guide holds near $3.3 +13% 25% 35%
Middle: reset to ~$3.00 with a bridge -1% 30% 35%
Cut: no bridge, margin under 10%, guide-down -13% 45% 30%
EV of buying now -2.9% +0.3%

The -13% comes from 7/28–29, when the stock fell 13.6% in two sessions. At your own odds, buying now is a zero-EV bet. It carries a fat left tail and an invalidation that doesn't protect against the event.

Waiting isn't free, because a clean print gaps up and you miss part of it. Suppose a clean print gaps +8%, mirroring 7/28, leaving ~5 points to your target. Waiting then returns about 0.25 × 5 = +1.3% on my odds and 0.35 × 5 = +1.8% on yours. Both beat buying now. Waiting only loses if a clean print captures more than ~12 of your 13 points in one gap. This is a simplification, but it's directionally robust.

Starter sizing and the invalidation level

  • Your invalidation is 0.7% away. A close below $53.88 is 0.66% under $54.24, against an ATR of 2.7%, and today's intraday low of $53.58 already traded through it. It will either be noise or, against an earnings gap, will not help. It covers drift but not the print, so size is the only real protection.
  • -9% understates the experience. The gap-sizing case uses 7/28's one-day -8.9%. The following session took the two-day move to -13.6%.
  • Q2 is already public. The snapshot's TTM includes it, so the market has seen whatever Q2 showed. The stock went from $69.33 to $54.24 after that. A "recovering Q2" is old information the market has already sold on, and the open question is guidance.

What I'm not saying

I'm not arguing for a short. RSI is 37.7, not oversold, but no Z-score is at -2. The revisions are public, and ADX at 15.8 says range-bound, not trending. A short into the print has its own symmetrical gap risk. My case is narrower: don't buy before the number, and don't call it asymmetric.

What would move me

  • An itemized bridge in which the Q4/Q1 charges are named and quantified, with total add-backs of roughly $1.10–1.50 a share.
  • Q3 operating margin at or above last year's 9.7%.
  • Guidance whose midpoint is near $3.3, or a reset with that bridge.
  • A close above $58.47 with an OBV higher low.

These are nearly your add triggers. If your mandate can't absorb a gap, you'd wait anyway. I'd go further: even if it can, your own 0.8–1.0 odds don't pay you to take that gap before the print. Bear Analyst: # Bear Closing: Your Clean Case Is a Re-Rating, and the Price Already Assumes the Rest

We agree the bridge and the clean-to-cut odds decide this, and that the print resolves both. I'll keep the concessions short and spend the rest on three places where your closing is weaker than it reads.

What I concede

  • The target table doesn't prove EPS cuts. The targets may sit on a different year's EPS, and Goldman's -28% includes a rating change. I'm withdrawing "four of four cuts means analysts saw lower EPS" and moving my cut bucket from 45% to ~35%. I won't go to your 25-30%, because nothing in the data supports that either.
  • The shortfall isn't volume. The year-over-year margin gap is also closing: about -12.9 pts in Q4 (15.0% to 2.1%), -7.3 in Q1, and -1.7 to -3.9 in Q2 (13.1% on your reading, ~10.9% if you back it out of net income). That is your best evidence.
  • Q4 isn't clearly soft on margin. Q4'24 was 15.0%. It was also well above the other nine months of 2024 (~10.8%, derived), so one quarter doesn't set a norm. Benchmarking off 9M'25 (12.2%) gives a ~$0.88B shortfall, or ~$0.83 a share. That is close to your $0.95, so I won't fight over it.

Your two questions

1. If FY25 adjusted EPS is $2.88 or higher, does the +15% row become central? Only if $3.31 is a next-twelve-months or FY27 number. If it is FY26, FY25 is the wrong base, because H1'26 is already banked. GAAP H1 EPS is ~$0.81 against $1.15. Say H1'26 adjusted merely matches H1'25, which is the best case where every dollar of shortfall is an excluded charge. Then the full +$0.43 lands in H2, and on an H2 base of roughly 45-50% of the year that is about +30%, not +15%. Any residual Q2 weakness makes it steeper. The horizon is unlabeled, so this is conditional. But the lookup you propose doesn't settle it unless you also know which year $3.31 belongs to.

2. What explains ~$0.95B other than discrete items or a price/cost break that had faded by Q2? Nothing I can name, and that is my point. "Largely faded" isn't "gone." Q2 is the seasonally strongest quarter, and it still shows a ~$110-245M operating income gap to last year (13.1% or ~10.9% against 14.8% on ~$6.35B). Without a bridge, nobody can say how much of that residual is a charge. The macro file also lists input costs as a live pressure, with oil near $103, hot inflation and mortgage rates at 3-year highs. I can't date when that pressure began, but it is a candidate that isn't a one-off.

Your clean case is a re-rating

This is what I think your tables miss. The price is already 16.4x × $3.31. Your clean bucket is defined as "guide holds near $3.3," and that is the status quo the stock already prices. Getting to the +13% target of $61.44 means 18.6x on the same EPS, a 2.2-turn re-rating. That has to happen with:

  • Dec hike odds at 78% and "no 2026 cuts" at 97%
  • the price below all three moving averages
  • the Viessmann zone at $61-62

The re-rating isn't impossible, since the multiple was higher at the $75.73 high. But it is a second bet on top of the print, and it makes the +13% generous to the buyer.

The math at everyone's odds

Clean pays +13%, the middle bucket -1% and a cut -13%. Waiting after a clean +8% gap still leaves ~+5%.

Odds (clean / middle / cut) Buy now Wait Difference
35 / 35 / 30 (yours, 0.9 ratio) +0.3 +1.75 -1.5
35 / 37 / 28 (your 25-30% cut) +0.5 +1.75 -1.2
30 / 35 / 35 (my revised) -1.0 +1.5 -2.5

Buying early only wins at roughly 45 / 30 / 25, a clean-to-cut ratio near 1.8. That is about double your own 0.8-1.0. The alternative is a clean gap of 12 points or more, which would leave waiters almost nothing. That is the 7/28 two-day scale, and it came on a stock that had been at $69, not at $54.

Even on your most generous row, you take a 28% chance of -13% for a +0.5% expected value, and that expectation includes the unpriced re-rating. You called this a sizing question, and I agree. But the sign favors waiting at every odds set either of us has proposed.

The starter

A third-size position scales both tails and doesn't change the sign. The cost is behavioral. The hardest call after the print is the middle bucket, "reset to ~$3.00 with a bridge," and holding shares pushes you to read it as clean. Your invalidation also fires after the gap, so it tells you when to admit the thesis failed, not how to avoid the loss.

Your Q3 margin test of ≥9.7% is a soft hurdle. It is last year's already-depressed quarter, below FY24's 11.8% and about even with FY25's 10.0%. A pass is flat year over year at a level that gets nowhere near $3.31. The itemized bridge and the guide are the real tests, and they are the same things I'm waiting for.

Where I land

I'm not arguing for a short. RSI at 37.7 isn't a signal, ADX at 15.8 says range-bound, and a short into the print has the same gap risk in reverse. My case is that you shouldn't buy before the number. Clean means unchanged EPS plus a re-rating, and that is a lot to ask in this rate environment.

What moves me: - An itemized bridge showing $1.10-1.50 a share of add-backs, with the Q4/Q1 charges named and sized - Guidance near $3.3, or a reset to ~$3.00 with that bridge - Q3 margin at or above 9.7%, as a floor - A close above 58.47 with an OBV higher low

If your mandate can absorb -13%, a starter of no more than a third is defensible. At your own odds it earns about nothing for that risk. Bear Analyst: # Bear Final: At Your Own Numbers, You Haven't Found an Edge

You wrote "I'm not claiming an edge before the print," and I agree with that. My case was never a short. It is that you shouldn't take an unhedgeable gap risk without being paid for it. Here is what you've earned and where the argument still lands.

What I concede

  • The target drops out of the timing math. Buy-now minus wait is P(clean)×G − P(middle)×1 − P(cut)×L, with no target term. The re-rating objection is about whether to own the stock, not when. One side effect on my own numbers: my +1.75 for waiting assumed ~5 points left after a clean gap. If a clean print only reaches ~+8%, waiting earns about zero. The difference between the two strategies is unchanged.
  • Your blend logic is right. If the middle and cut outcomes trade below 16.4x, the clean outcome must trade above it. "Clean is the status quo" was wrong as an expectation.
  • I mixed windows. Pairing +8 with −13 was inconsistent, so I'll use matched windows below.
  • I mislabeled my own table. I called 35/35/30 a "0.9 ratio," but it is 1.17. That row was generous to you.
  • Dividend coverage is ~2.7x on FY25 FCF, not 2.2x. Your correction stands.
  • I'm dropping the 58.47 close and OBV higher low as a precondition. It was a filter for adding, not a requirement for a first purchase. The waiter buys after the print on the bridge and the guide, which removes your "10–12 points higher" cost.

Where it still lands

Using your stated inputs (28% cut, clean-to-cut 0.8–1.0, up to 1.15 at the top) and matched windows:

Clean / middle / cut Clean:cut Buy − Wait, one-day (+8 / −8.9) Buy − Wait, two-day (+13 / −13.6)
22 / 50 / 28 0.8 −1.2 −1.4
25 / 47 / 28 0.9 −1.0 −1.0
28 / 44 / 28 1.0 −0.7 −0.6
32 / 40 / 28 1.15 −0.3 0.0

Buying early reaches break-even only at the top of your range and only in the two-day window. With symmetric windows the gap is smaller than in my last table, but its sign doesn't change.

Your blend point also helps me. If today's price is a fair probability-weighted blend, buying now has zero expected value by construction. For "priced in" to be an edge, the market has to be over-weighting the cut. You said yourself that the sources can't resolve a 7-point difference in cut odds, so the edge is asserted rather than shown.

At one-third size, this is worth −0.2 to −0.5 points of a full position. That isn't a thesis-level disagreement, and I won't dress it up as one. What remains is a left tail your invalidation can't stop, because a gap trades through it. There is also the middle-bucket bias you've already agreed to pre-register against.

The gross margin test

I accept it, but it only works in one direction, so I'm committing to how I'll read it now:

  • Flat gross margin year over year in Q1'26. The ~7-point operating margin drop then sits below the gross line, in restructuring, impairment or other items. That favors discrete charges, and I'd move toward you substantially.
  • Gross margin down sharply. This is ambiguous. COGS can hold warranty, inventory and other charges as well as a price/cost squeeze from oil near $103. I wouldn't move on that alone and would need the footnotes.

The open item

The fiscal year behind $3.31 may matter more than the FY25 adjusted EPS lookup. If it is FY26, H1 is already banked, and even the best bridge row needs ~+30% in H2. That is hard to square with 2–4% revenue growth and a ~$110–245M Q2 operating income gap to last year. The print should show it. Carrier has historically reported in late October, but the date isn't in the data, so verify it.

My pre-registered buckets

  • I become a buyer: an itemized bridge of ~$1.10–1.50 a share with the Q4/Q1 charges named and sized, and guidance near $3.3 (or a ~$3.00 reset with that bridge and margin back above 10%). The fiscal year of $3.31 must be identified and the implied growth must be reasonable, and gross margin must be consistent with discrete items.
  • Middle: a ~$3.00 reset without a full bridge, or margin at 9.7–10%. I stay out, and so should you, rather than relabel it as clean.
  • Avoid: no bridge, margin under 10%, or a guide-down. Then the 16.4x is on an EPS that doesn't exist.

If your mandate can absorb a −13% gap, a third-size starter costs you a few tenths of a point in expectation at your own odds. It is defensible but not compensated. Buy the print, not the anticipation.

Research Manager

Recommendation: Underweight

Rationale: This debate narrowed a lot, and that narrowing is what decided it. The bull opened with 'bad news is priced in' and a 2.5:1 setup. By the end he had conceded most of the supporting points. The payoff is roughly symmetric: about -13% to the gap or fundamental case against +13% to the 200 SMA. The stop-based 2.5:1 ignores gap risk around Q3. The sentiment sample, the CEO's stale $1M buy and analyst targets are not evidence of a floor. The 13.1% margin field is unlabeled and still down year over year. And the bull said himself he is 'not claiming an edge before the print.'

The bear conceded real ground too, and I credit it. Viessmann looks like a scheduled seller rather than a ceiling. The Q1 liability jump looks like a reclassification, so refinancing is a flexibility issue, not an EPS one. 'Four of four target cuts' does not prove EPS cuts, so the bear's cut odds came down from 45% to about 35%. The bear also accepted that the ~$0.95B of Q4'25/Q1'26 operating-income decline isn't explained by volume, and that Q2 net income of ~$455M (derived) was not a third trough quarter.

Why the bear still wins, modestly: - The whole valuation case rests on $3.31 of forward EPS. Neither side could verify it. TTM GAAP EPS is $1.38, FY25 GAAP was $1.72, and 10-13% margins only produce about $1.69-2.20 of GAAP EPS. Reaching $3.31 needs roughly $1.10-1.50 a share of add-backs that nobody has itemized. If $3.31 is an FY26 figure, H1 is already banked at ~$0.81 GAAP versus $1.15 last year, and H2 needs about +30% even in the best case. - Using matched one-day and two-day gap windows, buying before the print is negative or break-even at every odds set either side proposed, including the bull's own 28% cut probability. If today's price is a fair blend of outcomes, early exposure has zero expected value by construction, and an unhedgeable left tail of about -9% to -13%. - Everything independent of the forecast leans the same way. The trend is down on all timeframes, with price below all moving averages. OBV is at a new low (-93.6M versus -81.9M at the 9/18 low) while price is higher. Every revision this month was a cut. December hike odds are 78%, and no 2026 cuts is priced at 97%.

The margin of victory is small: tenths to about 1.5 points of a full position. Neither side argued for a short, since ADX of 15.8 says range-bound and gap risk cuts both ways. So this is Underweight, not Sell. The case is to reduce exposure into an unverifiable binary event and let the Q3 print, expected around late October but unconfirmed in the data, decide whether to rebuild.

Still missing from the evidence: the earnings date, FY25 adjusted EPS, which fiscal year $3.31 refers to, Q1'26 gross margin versus a year earlier, the Q2 10-Q margin, Viessmann's remaining stake and any lock-up, and peer multiples.

Strategic Actions: 1) Pre-print positioning (sizes relative to a standard allocation): - Existing holders: trim to about 50% of a standard allocation before Q3 earnings. Prefer selling into strength in the $55.2-56.8 resistance band. - If no bounce comes, finish the trim at market no later than 2 sessions before the confirmed report date. Verify that date; late October is the historical pattern, not a data point. - Do not initiate or add before the print. For a desk that must hold some exposure, the cap is about one-third of standard, and only if the mandate can absorb a -13% gap. - Do not short. Gap risk is symmetric, and RSI 37.7 / ADX 15.8 give no trend-short signal.

2) Risk control: price stops do not protect against an earnings gap, so size is the protection. The $53.88 level (9/18 close) is only 0.7% away against a 1.45 ATR, so treat it as noise, not a stop. Between now and the print: - A close below $52.96 on rising volume is a reason to finish the trim immediately. - Hedging with options is optional; implied volatility and option prices are not in the data, so price them before using them.

3) Pre-print homework for the trader or PM: - Look up FY25 adjusted EPS. - Confirm which fiscal year the $3.31 refers to. - Pull Q1'26 versus Q1'25 gross margin. Flat gross margin points to discrete charges below the gross line, which is bullish. A sharp drop is ambiguous and needs the footnotes.

4) Post-print buckets, written down now and applied mechanically: - CLEAN: an itemized GAAP-to-adjusted bridge of about $1.10-1.50 a share, with the Q4/Q1 charges named and sized. Guidance near $3.3, with the fiscal year identified and reasonable implied growth. Q3 operating margin at or above ~10%. Gross margin consistent with discrete items. - Action: rebuild to a full standard allocation in two tranches, half after the print and half on a daily close above $58.47 with an OBV higher low. - Upgrade to Overweight if guidance is raised. - Take partial profits at $61-62 (the 200 SMA, Goldman's target and the prior Viessmann block price). - MIDDLE: a reset to about $3.00, with or without a full bridge, or margin of 9.7-10%. Stay at the reduced ~50% size with no adds. Do not relabel this as clean. - CUT: no bridge, margin under 10%, or guidance implying EPS well under $3.00. Exit the remaining position. A post-print close below the January low of $49.67 confirms the thesis break.

5) Re-evaluate the rating after the print and after the three lookups. Also flag any new Viessmann block sale as a reason to delay re-entry.

III. Trading Team Plan

Trader

Action: Sell

Reasoning: The research plan's Underweight maps to a Sell: reduce exposure into the unverifiable Q3 print rather than short. The $3.31 forward EPS behind the valuation case can't be verified against TTM GAAP EPS of $1.38. Buying before the print has zero or negative expected value across the odds sets from both sides, with an unhedgeable left tail of about -9% to -13%. The technicals agree: all three SuperTrend timeframes are DOWN, price is below the 10 EMA, 50 SMA and 200 SMA, and OBV is at a new low (-93.6M) while price holds above the 9/18 low, a negative divergence. The MACD histogram has fallen four sessions in a row. The rating is Sell/Underweight rather than a short because ADX of 15.8 says the market is range-bound and gap risk cuts both ways. The earnings date is unconfirmed and should be verified. Sell into any bounce toward the 55.2 resistance (10 EMA and Bollinger middle, with 56.4-56.8 above it). If no bounce comes, finish the trim at market at least 2 sessions before the confirmed report date. A close below 52.96 on rising volume means finish the trim immediately. Price stops don't protect against an earnings gap, and the 53.88 close is only about 0.7% away against a 1.45 ATR, so it is noise rather than a stop. The 58.47 level (daily SuperTrend stop) is the thesis-invalidation level, where a daily close above it would end the reduced-exposure stance.

Entry Price: 55.2

Stop Loss: 58.47

Position Sizing: Portfolio holdings weren't provided, so size relative to a standard allocation. Existing holders: trim to about 50% of a standard allocation before Q3 earnings, selling into strength in the 55.2-56.8 band. Do not initiate or add before the print. If the desk must hold some exposure, cap it at about one-third of standard, and only if the mandate can absorb a -13% gap. Do not short. Rebuild only after the print, via the plan's CLEAN/MIDDLE/CUT buckets.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: I'll open, since nobody else has spoken, and I'll answer the objections I expect from both sides.

People will call selling CARR the cautious move. I think holding full size into this print is the comfortable move, and comfortable isn't the same as smart. The aggressive play is acting before the catalyst, with a plan, instead of waiting for the chart or the earnings release to give you permission.

Start with what the tape says. All three SuperTrend timeframes are down, and price sits below the 10 EMA, 50 SMA and 200 SMA. Closing highs have stepped down from 69.33 to 65.69 to 59.71 to 56.37, and closing lows from 59.92 to 57.25 to 53.88. That's a staircase, not a base. The one bounce we got, from RSI 27 on September 18 to 46 on October 6, never reached 50, and the MACD histogram has now fallen four sessions in a row. OBV is at a new low of -93.6M while price holds above its September low. That's distribution, and it means somebody is selling into every pop.

Now the objection I expect from the "don't sell the lows" crowd. This isn't a washout. RSI is 37.7, not below 30. No Z-score is at -2, daily is -1.52. TD-9 shows no exhaustion on any timeframe. The oversold bounce already happened and failed. Selling a stock that's 28% off its high isn't selling capitulation, because capitulation hasn't shown up.

Then there's the valuation bull. 16.4x forward looks cheap, but it rests on $3.31 forward EPS against $1.38 TTM GAAP. Q1'26 GAAP EPS was 28 cents, down from 47, and operating income fell about 59% on revenue up 2.4%. My inferred Q2 is around 53 cents, and that's my back-out from TTM, not a reported number. The $3.31 may well be an adjusted figure and perfectly legitimate, but nobody on this desk can verify it from the data, and you don't pay up for a number you can't check ahead of a binary event. Meanwhile the people who know the model best are cutting. Goldman went $85 to $74 to $61 and then downgraded. RBC, Bernstein and Deutsche all cut too. If someone points out that those targets still sit above the price, remember that every one of them has been a ceiling that got lowered, never a floor.

The macro doesn't help. A December hike is priced at 78%, no cuts in 2026 is 97%, mortgage rates are near three-year highs, and oil is around $103. For a 1.29-beta building products name with thin liquidity (current ratio about 1.0) and, by my rough estimate, 3.5x net leverage, that's multiple compression. I'll concede recession odds are only 8%, which is exactly why this is a trim and not a short.

That brings me to the other direction. A conservative voice may say go flat or short, so why keep half? Because ADX is 15.8 and the market is range-bound, gap risk cuts both ways, and the sell-side has already lowered the bar. A "less bad than feared" print could squeeze this 8% to 10% in a day. Keeping half is the bold hedge against my own thesis. The arithmetic is simple. If we get filled near 55.2 and the stock rips to the 58.47 invalidation, the half we sold costs about 6%, roughly 3% of the full position. If the left tail of 9% to 13% hits, the half we sold saves about 4.5% to 6.5% of the full position. That's a trade I'll take repeatedly.

The plan also doesn't depend on getting lucky. If we get a bounce to 55.2, we sell strength. If we don't, we finish the trim at market two sessions before the print. If we close below 52.96 on volume, we finish immediately. Three paths to the same result. The 53.88 level is only 0.7% from the close against a 1.45 ATR, so treating it as a stop would be noise trading, and the plan correctly ignores it.

The best bull card is the CEO's $1M purchase at $52.62, and I give it real weight, because the stock ran to 75.73 afterward. But it's 11 months old, small against a $45B cap, and since then Viessmann sold roughly $750M at $62.01 and GAAP margins fell off a cliff. The sell-side rotation toward Trane, which Goldman upgraded the same day it downgraded CARR, tells me capital has somewhere better to go. The backlog claims come from a StockTwits post, so I'd treat them as soft, but the opportunity cost of dead money in a broken chart is real.

I'm not hiding the holes. The earnings date is unconfirmed, the statements stop at Q1, sentiment confidence is low, and today's volume bar may not be final. Those are reasons to size this as a trim and verify the date. They aren't reasons to sit still. I back the Sell. Aggressive Analyst: Let me start by giving back what you've earned, because it makes the rest harder to wave away.

Conservative, your arithmetic is right and mine was loose. An 8% to 10% squeeze from 54.24 lands around 58.6 to 59.7, past my 58.47 line. The half I sell at 55.2 then costs 6% to 8%, which is 3% to 4% of the position, not 3%. You're also right that 52.96 is only about 0.9 ATR away, so a second half sold there goes out around 2.4% under today's close. And you and the neutral are both right that a plan that opens with "don't wait for permission" shouldn't hang its first sale on a bounce. So I'll take the unconditional first tranche. A quarter sold in the next day or two costs about 0.4% of the position against a 55.2 fill, which is cheap. I'll also drop the 3.5x leverage, the 53-cent Q2 and the $3.31 from any sizing math. They're back-outs and flags. The tape, the event and the mandate should set the size.

Here is where I won't move. The worry that the bounce may not come is smaller than it sounds. Yesterday's close was 55.03, and the limit is 0.96 points above today's close, about two-thirds of one ATR. If the print lands in the usual late-October window, we have roughly nine to eleven sessions. That's a back-of-envelope view, not a tool output, and the downtrend drags on it. Even haircut hard, touching 55.2 in that window looks better than a coin flip. If it fails, the market-order backstop costs about 2% on a tranche.

On the retained half, conservative, you say it risks more than it gains: 4% to 5% in the squeeze against 4.5% to 6.5% in the tail. Those magnitudes are within a point or two of each other, and neither carries a probability, because nobody here has the implied move. Cutting from a half to a third therefore rests on the gap being more likely than the squeeze. Four firms have already cut or downgraded, so you'd be betting the print is worse than a bar that has been lowered four times. The tape and the July precedent make that possible, but not likely enough to turn a sizing preference into a ceiling. Your point that a gap skips every support level also proves too much, as the neutral said. If levels don't matter in a gap, the answer is zero, not a third. I'll also side with the neutral on opportunity cost. Portfolio context isn't provided, and in a benchmarked book a 9% pop while we're light is a real relative loss. Regret isn't a criterion, but tracking error is.

Neutral, you caught me on September 18. I said the oversold bounce already happened and also that capitulation hasn't shown up, and you say I can't have both. I don't need both, because either reading says trim. If 21 million shares at RSI 27 was the flush, the retest should hold on volume. Instead we have 3 to 5 million share sessions and OBV at a new low. If it was just third-Friday volume, there was no flush, and there's more room down. I'll retire the word capitulation and say there's no confirmed washout. You're also right that ADX describes the last few weeks, not the shape of a gap, so I'll stop leaning on it. The case for staying near half rather than flat is that nothing here shows which way the surprise breaks.

On the squeeze, a no-catalyst 4.6% drift and an earnings gap are different distributions. But 8% to 10% is my number, not a measured one, and that's exactly why I back your call to pull the options chain. If the implied move is well under 8%, both tails shrink and we can hold near half without further argument. If it's at or beyond the 13% end, I'll go to a third. That number should set the final tranche, not either of our guesses.

The trim is also the high-reward side of this trade, not just protection. Shares sold at 55.2 buy back about 12% to 17% more stock if the gap lands at 47.2 to 49.4. The staged rebuild in the trader's plan is how we collect that.

On Viessmann, I'm with the neutral. I can't check the company's trading window or the earnings dates behind the two blocks from this data, but if both followed earnings by several weeks, the supply risk comes after the print. That argues for a staged rebuild, not a bigger sale now.

So I'll take your structure, neutral. Confirm the date today and sell a quarter with no price condition. Rest a limit for another quarter at 55.2 to 55.6, and keep the market backstop two sessions before the print and the close-below-52.96 trigger. Let the options chain and the mandate decide whether we finish near half or at a third. The default stays at half, because that's the trader's plan and nothing here gives a reason to prefer a third beyond taste. 58.47 is a signal to reassess, not a stop. And no short. A short needs an edge on the print, and ours is in the tape.

We're arguing over a handful of basis points of a standard allocation. The date and the implied move are worth more than anything else we've said. Aggressive Analyst: Neutral, I'll take your structure almost as written, so let me say what I'm giving up and where I still push back.

Conservative, you're right on three points. Four price-target cuts aren't four estimate cuts, and the reports give no reasons or consensus numbers. I'm retiring "the bar has been lowered four times" as sizing evidence. It's a direction, not a number. You're also right that the tape is lopsided. The best rally off the September low was 4.6% on closes, and the first July session alone fell about 8.9%. My 8% to 10% squeeze is a guess. And the buyback point cuts both ways. Selling at 55.2 and rebuying at 47.2 to 49.4 does buy back 12% to 17% more stock, and the retained piece forgoes that. That's the cost of keeping it, and I accept it.

I'll also move on the trigger. I called 53.88 noise, and as a stop on a bare close it is. But Neutral's version requires a close below about 53.9 on volume well above the 3 to 5 million baseline, which is the same trigger the technical report names as the bearish break. Today's 4.6 million is inside the baseline, and it may not be final. I'd put "well above" at roughly double the baseline, which is my judgment, not a tool output. That conversion costs about six-tenths of a percent of the position against a 55.2 fill, and it means we aren't waiting for 52.96, which is another 2% lower. I can live with that.

Here is where I still disagree. Conservative, "when it's a tie, the smaller position wins" is a risk preference, not a finding. It's right only if losses should be weighted more heavily than gains, and that's what the mandate decides. You told me yourself that nobody here knows the mandate. In a benchmarked book a missed squeeze is a real loss. In an absolute-return book it costs nothing. So the tie-break can't set the default for an unknown book.

Your last step has the same problem. It takes three confirmations to hold half and none to go to a third. But the date, the implied move and the loss budget are each about one lookup away. The advisory is already out. The price history shows the past earnings-day moves. The loss budget is a number the caller already has. The argument is only about the hours before someone looks, and nothing executes at the half-versus-third margin until the limit fills or a trigger fires. By then the inputs will be in.

I also want to give the squeeze a mechanism, not just a percentage. The world report names what would pull hike odds down: a soft CPI, a lower 10-year yield, oil staying near or below $103. A 1.29-beta, rate-sensitive name sitting 12% under its 200 SMA could move sharply on any of those, with or without its own print. I'm not putting a probability on that. But it means the upside isn't only my number. Goldman also downgraded Lennox, so a peer print can lift this stock as easily as hit it.

The peer calendar is still your best new point, and I take it. Nobody has checked when Trane, Johnson Controls and Lennox report. If one lands inside the window, the first sale goes to a third, as Neutral said. I'd add that the gap between 67% and 75% held for nine sessions is eight points of position. That's worth a calendar check, not a new thesis.

On Viessmann, you're right that supply on the way up caps a squeeze. That argues for selling into the 55.2 to 56.8 band, which is already the plan. It doesn't argue for selling more at 54. Check the Form 4 and 13D/G filings for the remaining stake and any pre-arranged selling plan.

On the implied move, you said it's a central estimate, not a cap. True, but every sizing input is that. An imperfect number is still better than the 13% I've been carrying around, which is one sell-off with an unnamed catalyst.

So here is where I land:

  1. Today: confirm the date, check the peer calendar, and pull the past earnings-day moves, the Q2 guidance and consensus, and the options chain if possible.
  2. Sell a quarter at market now with no price condition, and make it a third if a peer reports inside the window.
  3. Rest a limit for the next quarter at 55.2 to 55.6. It's 0.66 ATR away, and the stock closed at 55.03 yesterday.
  4. A close below about 53.9 on roughly double-baseline volume converts that limit to market. A close below 52.96 on volume, or two sessions before the confirmed date, finishes the job.
  5. Retained size equals the loss budget divided by 13%, capped at about half, with tracking error as the floor if the book is benchmarked. A third is the fallback only if the caller can't run that division, and it takes a minute.

58.47 is a signal to reassess, not a stop. The rebuild comes in stages after the print, with the proceeds ready to buy lower if the gap comes. There's no short, because we have an edge on the tape and none on the print. I back the Sell. Aggressive Analyst: I'll start with what I'm giving up, because most of what's left is small.

Conservative, you're right about the trigger. I built my volume filter for a decline that hasn't needed volume. The last eight sessions ran three to five million shares, and OBV still slid about 23 million from 9/25. So I'll take two consecutive closes below about 53.9, or one on clearly heavy volume. I'll also drop the volume requirement on the 52.96 leg. A close under the September intraday low is a new low for the whole move, and the plan shouldn't wait for a kind of day this stock doesn't need. I'll also accept the quarter becoming a third if a peer reports inside the window or the date can't be confirmed by tomorrow's close. That costs about 0.15% of the position and resolves with one lookup.

Neutral, you're right that I over-read the trader's plan. It has both numbers: a trim to about half, and a cap near a third if the desk must hold exposure and can absorb a 13% gap. So I'll stop calling half the default. The plan gives a corridor, and a formula should pick the point in it.

We don't need to fight over the default, because retained size is loss budget divided by stress gap. A third at 13% and a half at 9% both cost about 4.3% to 4.5% of a standard allocation. If the options chain shows a 5% implied move and the stress gap is 10%, the same budget supports roughly 43% retained, between our two numbers. The only live question is the stress gap, and here I'd adjust Conservative's rule. Taking the larger of the worst recent reaction and twice the implied move always picks the biggest candidate. The biggest candidate we have is one two-session window that may not be an earnings reaction.

Neutral recalled that the July FOMC decision fell on the 28th and 29th. I remember the 2026 calendar the same way, with September 15-16 and October 27-28 as the neighboring meetings. I can't confirm that from the tools. But the Polymarket December market resolves on 12/09, which fits a December 8-9 meeting, so the schedule is at least consistent with the data. If it's right, both big air pockets in this tape sat on Fed meetings. That means July 28-29 and the 13 and 21 million share days on 9/15 and 9/18 may have been rate shocks as much as earnings shocks. That makes 13% a less clean earnings stress number. It also makes an October 27-28 overlap with a late-October print a real stacking risk. So I'd take Neutral's version: the larger of twice the implied move and the worst of several earnings-day moves, never a single observation. If the print lands within a day of the FOMC decision, the backstop keys off whichever comes first. If the book is benchmarked, the same stress multiple applies to the upside, since an unmanaged squeeze is a tracking-error event too.

On the rebuild, I agree that price can't be the trigger on a gap through every level. But I'd gate the first tranche on the release and the call, not the 10-Q. A Carrier release normally carries guidance, the GAAP-to-adjusted bridge that tells us whether $3.31 is real, and a condensed balance sheet. Markets digest those fast. A rebuild gated on debt detail that arrives days later buys after the move. So I'd make the first tranche small and conditional on release content, and let price confirm the later ones.

Neutral, I also agree on the proceeds. Don't rotate into Trane, Johnson Controls or another rate-sensitive building name before the print. That's the same housing, rates and peer-print risk we're trying to cut. Hold cash or something broad. If a peer reports first, we get free information, and it can lift this stock as easily as hit it.

I still think the Sell is the aggressive trade, not the timid one. A quarter now and a quarter into strength turns a binary event into one where we hold cash whichever way it breaks. If it gaps down, the proceeds buy 12% to 17% more stock than we sold. If it squeezes, we still own enough to participate, and the rebuild is staged. The half-versus-third question is worth roughly 1.5% to 2% of a standard allocation either way. The decision that matters is getting from full size to something between 50% and 67% sold, and getting there early.

Here's the plan I back. Today, confirm the earnings date, the ex-dividend date and the peer calendar. Pull past print reactions, the Q2 guidance and consensus, the options chain if available, and the mandate number. Sell a quarter at market now, or a third if a peer is in the window or the date can't be confirmed. Rest the next quarter at 55.2 to 55.6, adjusted for the dividend. Selling ahead of the ex-date costs nothing real, since the price drops by about the dividend. Convert the limit to market on two closes under about 53.9 or one on heavy volume. Finish on any close under 52.96 or two sessions before the print, whichever comes first. Set the final retained size by loss budget over stress gap, capped at half, with a third as the written default if nobody runs the division. A hard mandate limit overrides either. Treat 58.47 as a reassessment signal, not a stop. Rebuild in steps after the print, and don't short. Our edge is in the tape and we have none on the print. I back the Sell. Aggressive Analyst: Most of what's left is operational, so I'll concede what's earned and then say where I still stand.

Conservative, you're right about July. The 8.9% drop came on the 28th, before any Fed decision, so I can't use the FOMC overlap to discount that number. If anything it makes a Carrier-driven move more plausible, since the tools have the company reporting in late July, though that's memory and the catalyst still isn't named. I'm retiring the idea that the left tail is padded by macro noise. The first-session gap of roughly 9% is real and is the part nobody can manage. I'd still test the formula at both 9% and 13%, because the second session gave a liquid $45B name some chance to act, but I'm no longer treating 9% as the friendly number.

I still disagree that the burden of proof sits on whoever lowers the stress gap. A stress number is an input, not a null hypothesis. We all agreed one observation isn't enough, so pull the last several print reactions and the implied move and use what comes back. I'll accept 13% as the placeholder until then, but not as a presumption.

On the quiet path, you found the real hole. If CARR drifts between 53.9 and 55.1 for nine sessions, my limit never fills and my conversion never fires. I'd been treating the 55.2 touch as likely and moved on. Neutral's time stop fixes it: if the limit hasn't filled about five sessions before the confirmed print, it converts to market. I'll take that. It costs a few tenths of a percent of the position and gets us to about half sold on every path. The drift is also a warning sign in itself, since OBV kept making new lows through it.

You're also right that the 12% to 17% rebuy isn't banked. It depends on the release content. I'd call it optionality, not a forecast. Cash is what turns a gap into an opportunity, and the staged, release-gated rebuild is how we collect it.

Neutral, your pattern point lands. Every unknown resolving toward the smaller number is a ratchet. My answer is deadlines instead of presumptions. The lookups are the print date, the peer calendar, the ex-dividend date, past print reactions and the mandate number. They take minutes, so set a cutoff at tomorrow's close. If they're done, the formula and the calendar decide. If they aren't, the written fallback is a third, and the fallback applies because someone skipped the work. That is not the same as assuming Lennox reports in the window. That is Conservative's memory, and I'd rather see the calendar than build on it. If it checks out, the first sale is a third and I have no objection.

You're also right to push me off "our edge is in the tape." The technical read is bearish to neutral, with ADX under 20, no Z-score at an extreme, and no reversal signal either way. The tape tells us not to be the marginal buyer and to sell into strength. It doesn't tell us which way the gap breaks. The case for the trim is event risk against inputs we can't verify, namely the $3.31, the missing Q2 statements and the unconfirmed date. That is also why it's a trim and not a short. I'll drop the 43% example for the same reason. A guessed stress gap and a missing mandate number can't support that precision, so it's a third or a half.

Your holdings point matters because we don't have the book. Everything here is in terms of a standard allocation. If the caller is overweight, the first sale is larger than a quarter. If they're already at or below a third, there's nothing to sell, and the instruction is not to add. If they're flat, stay flat and don't buy into the print.

What I'm holding onto is the shape of the trade. The Sell is the aggressive move because it gets us from full size to somewhere between 50% and 67% sold, early, on a confirmed date, with proceeds in cash or something broad instead of Trane or other rate-sensitive building names. I don't want to end up with a plan that says a third whatever the data shows. The half-versus-third question is worth a percent or two of one position, while the move from full size to a real trim is worth far more.

Here is where I land. Today, confirm the print date, the ex-dividend date and the peer calendar, and pull the past print reactions, the options chain and the mandate's loss number and any benchmark band. Sell a quarter at market now, or a third if a peer reports in the window or the lookups aren't done by tomorrow's close. Rest the next quarter at 55.2 to 55.6, adjusted for the roughly 24-cent dividend if the ex-date falls inside the window. Convert it to market on two closes under about 53.9, one close on clearly heavy volume, or five sessions before the print, whichever comes first. Finish on any close under 52.96, or two sessions before the print, and ahead of an FOMC decision if one falls in that stretch. Check that date, because I'm going from memory.

Retained size is the loss budget divided by the stress gap, capped at half, with a third as the default if nobody runs it. A hard mandate limit overrides, and conflicting limits go back to the caller. Treat 58.47 as a reassessment signal, not a stop. Rebuild small after the print, with the first tranche gated on guidance and the GAAP-to-adjusted bridge in the release, and price and the 10-Q confirming the rest. No short. I back the Sell.

Conservative Analyst

Conservative Analyst: You opened by calling full size the comfortable move. I don't disagree, and I'm not defending full size. The Sell is the right direction. What I object to is how much risk your plan still carries, and a few places where the argument is tighter than the data allows.

I'll grant you most of the tape: three SuperTrends down, price under all three averages, stepped-down highs and lows, and OBV at a new low. But follow it through. If this is a staircase with no capitulation and no TD-9 exhaustion, nothing says the floor is in. That is an argument for carrying less into the print, not for keeping half. I'd add that being 28% off the high doesn't make the stock cheap. A falling stock that looks cheap is not support.

On valuation, you said you don't pay up for a number you can't check ahead of a binary event. Apply that to the half you're keeping. It's still paying 16.4x on a $3.31 nobody can verify. You also lean on a 3.5x net leverage figure and a 53-cent Q2 that are both back-outs, the first from a debt-to-equity ratio and not a filing. I'm fine using them as flags, but be consistent. The honest reading is that the desk has no Q2 statements, the snapshot free cash flow of $862M conflicts with roughly $1.7B on the fundamentals report's own derivation, and the earnings date is unconfirmed. When the data is this incomplete, position size is the only control we have.

I won't fight you on the sell-side cuts or the macro. I'd only note that the 78% hike odds come from a market with under a million dollars of volume, so they're directional, not precise. Either way, oil near $103 and a current ratio around 1.0 make the retained half harder to defend.

Now the arithmetic, which I think is where the plan is weakest. You say a squeeze of 8% to 10% is the risk to the half you sell. From 54.24 that lands around 58.6 to 59.7, above your 58.47 line. So the sold half costs 6% to 8% against a 55.2 fill, or 3% to 4% of the position, not 3%. On the other side, a 9% to 13% gap from here is roughly 47.2 to 49.4. That's below the 52-week low of 50.24 and below the January low of 49.67. A gap like that skips every support level in the technical report in one print, so nothing is left to manage the exit with. And by your own numbers, the half you keep gains 4% to 5% in the squeeze and loses 4.5% to 6.5% in the tail. That half has more to lose than to gain. You called it a hedge against your own thesis, but it's the same instrument with the same risk at a smaller size. Missing a squeeze is an opportunity cost, not a loss of capital. Regret over a squeeze isn't a risk-management criterion.

I'm also not persuaded the plan is as mechanical as you say. You opened by saying not to wait for the chart to give you permission, but the plan waits for the chart twice: a bounce to 55.2, or a close below 52.96. The three paths also don't end in the same place. One sells half at 55.2. One sells at whatever the market gives two sessions before the print. One sells after a close below 52.96 on volume, which means the stock is already about 2.4% lower, nearly a full ATR, and the second half goes out lower than today. With ADX ticking up from 11.1 to 15.8 on a down day, that path isn't remote. You waved off 53.88 as noise, but your own trigger is only about 0.9 ATR away. The plan also depends on a date nobody has confirmed. "Two sessions before the print" means nothing until someone checks the PR Newswire advisory. The fundamentals report says Carrier has historically reported in late October, so the print could be close.

On the CEO purchase, you called it small and old, and I agree. But the Viessmann overhang doesn't clear when the print passes. He's sold two blocks, at $70.30 and then $62.01, and we don't know the remaining stake. Another block can hit the stock with no earnings catalyst at all.

Here is what I'd change. I'd sell a first tranche, about a third of the position, in the next session or two instead of waiting for permission. The cost versus a 55.2 fill is under 2% on that tranche, about six-tenths of a percent of the position, and it removes dependence on a bounce that may not come. I'd leave a limit order for the next tranche at 55.2 to 55.5. I'd treat one-third of a standard allocation as the ceiling going into the print, not the exception, and go lower if the mandate can't absorb a 13% gap on what's left. The trader calls that tail unhedgeable. More precisely, we have no options data on this desk, so we can't price a put spread, and an unpriced hedge isn't a hedge. I'd confirm the earnings date today and, if it can't be confirmed, work to the earliest plausible late-October date.

I'd also be clear about the 58.47 line. It isn't a stop on anything we own. It's a signal that the reduced-exposure stance may be over. Even a close above it leaves price below the 200 SMA at 61.44 and the weekly SuperTrend at 66.98, so any rebuild should come in steps after the print. And no short, for the reasons you gave.

I haven't heard from the neutral analyst, but I expect the case will be to hold through because the bar is lower and the stock sits on a floor that held in March and September. A floor is exactly what an earnings gap jumps over. I'd rather give up some squeeze than take a 13% gap on half the book. Conservative Analyst: Neutral, you're right that my one-third is a heuristic, not a derived number, and that half versus a third is worth a few basis points of a standard allocation. I'll also stop pushing "a gap skips every level" to its logical end, because zero isn't where I land. But the point survives if I state it properly. Levels can't protect the piece we keep, so the retained size shouldn't be picked off the chart. It should come from the loss the book can take in an unmanaged gap: take the single-name event loss the mandate tolerates, divide by 13%, and that's the maximum retained position. Nobody on this desk has the mandate, so nobody can run that division. That is why the default shouldn't be the larger number.

Aggressive, that's where I disagree with "the default stays at half." You said a third rests on the gap being more likely than the squeeze. When nothing shows which way it breaks and the payoffs are within a point or two of each other, the tie should go to the smaller position. The loss side is the one we can't manage, and the gain side is a missed opportunity the staged rebuild partly recovers.

The evidence also isn't symmetric. The best rally off the September low was 4.6% on closes. The July sell-off took the stock from 69.33 to 59.92 in two sessions, and the first session alone was about 8.9%, on roughly 16 million shares. The low end of the left tail is something this stock has done in a single day. Your 8% to 10% squeeze has nothing in the tape behind it, and you've said it's your number, not a measured one.

On the lowered bar, what we have is four price-target cuts, not four estimate cuts. Targets can fall because analysts will pay a lower multiple with a December hike at 78% and mortgage rates at a three-year high, while the EPS they expect stays the same. The reports give no reasons for any of the cuts and no consensus numbers, so we don't know the number the company has to beat. The print is also guidance, and the deterioration is mostly forward-looking: rates, housing, oil near $103. I'd call that inference, but a quarter that's less bad than feared can still come with a guide the market sells.

Your point about buying back 12% to 17% more stock at 47.2 to 49.4 is a good one, but it argues for selling more, not less. The retained half forgoes exactly that reward.

You're probably right that 55.2 is reachable, since it's 1.8% away with nine-plus sessions. But a touch only fixes the fill. Until it fills or the backstop fires, we hold 75% for up to nine sessions through CPI, Iran headlines, and the Trane, JCI and Lennox prints the world report flags and nobody has researched. A peer's bad print can gap this stock before its own date.

Neutral, on Viessmann, I'll accept that a blackout puts the supply after the print. Follow it through, though. The squeeze we'd keep half for then meets a seller on the way up, so it's less durable than 8% to 10% suggests. Two blocks is a thin pattern, we can't see his remaining stake, and a pre-arranged selling plan wouldn't care about a blackout. We can't see whether one exists.

Here is what I'd change in your structure, neutral:

  1. Confirm the date today, since the advisory is already out.
  2. Sell a third now with no price condition, not a quarter. The extra twelfth costs about 0.15% of the position against a 55.2 fill, and it gets us closer to the target before the peer prints.
  3. Rest the limit for the next piece at 55.2 to 55.6, aiming for a retained position of about a third.
  4. Move the immediate-finish trigger from a close below 52.96 to a close below 53.88–53.94 on volume. The technical report names that area as the bearish trigger and 52.96 as the next level. Today already traded to 53.58 and closed at 54.24, so requiring a close plus volume is the noise filter. Waiting for 52.96 gives away another 2% on the tranche.
  5. Go back up toward half only if three things clear: the date is confirmed, the implied move is in hand and not near the 13% end, and the mandate budget supports it. Even then, an implied move is a central estimate of size, not a cap, so it doesn't remove a July-style outcome.

58.47 stays a reassessment signal, the rebuild comes in steps after the print, and there's no short. We agree on Sell. The only disagreement is which way the default breaks while the options chain, the date and the mandate are all unknown. I'd rather miss a squeeze on a sixth of the position than hold an unhedgeable half through a gap I can't price. Conservative Analyst: I think we've converged enough that the size argument is now worth a few basis points of the position, so I'll say what I'm giving up and then where the plan can still fail.

I give up three things. Neutral is right that a bare close below 53.88 to 53.94 is too tight to be a trigger. It's about a quarter of an ATR from today's close, today's low already traded through it, and the 53.97 close on March 30 was followed by a 3.6% bounce. Aggressive is right that "the smaller position wins a tie" is a risk preference, not a finding, and whether a missed squeeze costs anything depends on whether the book is benchmarked. And a quarter versus a third on the first sale is about 0.15% of the position against a 55.2 fill. I'll take the quarter, with one condition. It becomes a third if a peer reports inside the window or nobody can confirm the date today. Neutral's first draft treated an unconfirmed date as a reason for a third, and I'd keep that.

Now what I'd still change. First, the volume filter. You both want the conversion trigger to need a close below about 53.9 on roughly double the 3 to 5 million baseline. Look at how this decline has actually happened. OBV has slid about 23 million since 9/25, and the technical report says the last eight sessions mostly ran 3 to 5 million shares. So much of the distribution has come on baseline volume, not heavy days. A trigger that waits for double-baseline volume is waiting for a kind of day this decline hasn't needed. The 52.96 leg has the same problem. The stock could grind through both levels on 5 million share sessions and trip neither, which would leave the date as the only unconditional leg of the plan. I'd keep the volume leg and add a second route: two consecutive closes below 53.9 also convert the limit to market. That filters a one-day poke like March, and it costs about the same six-tenths of a percent of the position you've already accepted.

Second, how the stress number gets used. I agree we should pull past earnings-day moves and the options chain. But an implied move is the market's expected size, not its worst case. Aggressive said that if it comes back well under 8% we can hold near half without further argument, and I wouldn't let it do that. If the July two-session drop of 13.6%, with 8.9% on the first day, was the Q2 reaction, which Neutral inferred and the tools don't confirm, then this stock already gave us that outcome on the last print. I'd set the stress gap at the worst of the recent reactions, or roughly twice the implied move, whichever is larger. I'd only take it below 13% if the history shows July was the outlier. The twice is my rule of thumb, not a tool output.

Third, the rebuild. Aggressive's point that selling at 55.2 and rebuying at 47.2 to 49.4 gets 12% to 17% more stock is right as arithmetic. But a gap to that area lands below the January low near 49.7 and under every level in the technical report, with a December hike priced at 78%. At that point the chart has nothing to say, so price can't be the rebuild trigger. The trigger has to be what's in the release: guidance, the GAAP-to-adjusted reconciliation that tells us whether $3.31 is real, and the debt detail. If Viessmann supply comes after the blackout, as Neutral argued, it meets the rebuild first. So the first rebuild tranche should be small and gated on those, not on a price.

Fourth, the order of constraints on the final size. In Neutral's corridor the loss budget over the stress gap is the ceiling and tracking error is the floor. Sometimes they'll cross, for example if the budget supports a third and the benchmark wants half. The ceiling should win, because one is a limit and the other is a preference. When nobody runs the division, the fallback is a third. You both accepted that, so I'd write it into the plan as the default, not leave it as an afterthought.

I'd add three items to Neutral's checklist. First, whether CPI or a Fed meeting falls inside the window, since the world report doesn't date them. Second, the ex-dividend date. A quarterly dividend of roughly 24 cents, by my math from the 1.74% yield, would take most of the 34 cents between today's close and 53.9 on its own. Third, the Form 4 and 13D/G check on Viessmann's remaining stake.

So the plan I'd back is this. Confirm the date today and sell a quarter now, or a third if the date or the calendar says so. Rest the limit at 55.2 to 55.6. Convert to market on two closes below 53.9 or one on heavy volume. Finish at 52.96 or two sessions before the print. Size the final piece off the loss budget and the worst recent reaction, with a third as the default. Treat 58.47 as a reassessment signal, rebuild in gated steps after the print, and don't short. I back the Sell. Conservative Analyst: I'll keep this short, since we've mostly converged and I don't want to invent disagreement.

First, what I'm giving up. Aggressive, you're right that the first rebuild tranche should be gated on the release, not the 10-Q. Debt detail that arrives days later means buying after the move. So the first small piece waits on guidance and the GAAP-to-adjusted bridge, and the 10-Q and price confirm the rest. Neutral, I accept that a benchmark band can bind as hard as a loss limit, and that two conflicting hard limits go back to the caller. I'm also glad we've written down a third as the default, with half as the cap when the division supports it.

Now where I'd push back. The first is the July story. We're all leaning on memory for the FOMC calendar, and mine matches yours: July 28-29 and September 15-16. But the decision comes on the second day. The biggest piece of the July drop, 8.9%, came on the 28th, the first day of the meeting, before any decision. The technical report names 9/15 and 9/18 as the heavy September days. Neither is a decision day, and 9/18 was the third Friday. So "both air pockets sat on Fed meetings" is true on the calendar but doesn't explain the sessions that did the damage. It could have been a Carrier event, or positioning. We don't know.

Either way, the stress gap should come from what this stock does on a catalyst, not from a theory about which catalyst it was. And if July was partly macro, that works against you. An October 27-28 FOMC on top of a late-October print is a stack, not a reason to discount the number. Lowering the stress gap is what raises the retained size, so the burden of proof sits on lowering it. I accept that we shouldn't use a single observation. Pull several prints and take the larger of the worst of those and twice the implied move. Until that comes back, 13% stays.

My second pushback is on Neutral's "most paths get us to about half sold within days." The technical report's base case is a range, with ADX under 20 and closes between 53.88 and 56.37 for three and a half weeks. I agree a touch of 55.2 is more likely than not. But the quiet path, where the stock drifts between 53.9 and 55.1 for nine sessions, fires neither the limit nor the conversion. We'd sit at two-thirds or three-quarters until the date backstop. I've already agreed that's only a few points of position. But it means the backstop is doing real work, and it's the one leg that depends on a date nobody has yet. So confirm the date first, before anything else.

On the peer calendar, my memory is that Lennox usually reports in the third or fourth week of October. Goldman downgraded it in the same action as Carrier. If that holds, the condition for selling a third instead of a quarter on day one is probably already met, and that debate resolves itself. Check it, but I'd assume a third until someone shows otherwise.

Aggressive, one more thing on the 12% to 17% more stock you'd buy back at 47 to 49. That's arithmetic about a rebuy price. Whether we get to rebuy there depends on what's in the release, so I wouldn't count it as banked.

Here is the plan I'd put in front of the caller. Today, confirm the earnings date and the ex-dividend date, pull several past print reactions and the options chain, and get the mandate's loss number. Sell a third at market now. Rest a limit for the next slice at 55.2 to 55.6, adjusted for the roughly 24-cent dividend if the ex-date falls inside the window. Convert it to market on two closes below about 53.9, or one on clearly heavy volume. Finish on any close below 52.96, or two sessions before the confirmed print, whichever comes first.

Set the final retained size as the loss the book tolerates divided by the stress gap, capped at half, with a third as the default if nobody runs the division. For example, 4.3% of a standard allocation supports a third at a 13% gap and about half at 9%. Keep the proceeds in cash or something broad, not in Trane or other rate-sensitive building names. Treat 58.47 as a signal to reassess, rebuild in gated steps after the print, and don't short. I back the Sell. Conservative Analyst: I'll start with what's earned, because it leaves very little standing.

Neutral, the ratchet point is fair as far as it goes. I let an unconfirmed date, an unchecked peer calendar and an unknown stress gap each pull toward a third, and the Lennox timing was my memory, not a lookup. I'm withdrawing "assume a third until someone shows otherwise." Aggressive's answer is the right one: a deadline. Everything gets looked up by tomorrow's close, and whatever isn't done defaults to a third automatically, with no extension and no vote. I'd only add that this isn't a ratchet, because the two errors aren't the same size. If we hold a third and the stock squeezes, we rebuild in steps. If we hold half and the stock gaps, there's no repair. That justifies a small fallback, and only a fallback.

Aggressive, you're right that a stress number is an input, not a null hypothesis, so I'll take 13% as a placeholder. I also accept your retreat from "our edge is in the tape," and I'd draw the consequence. If the tape can't tell us which way the gap breaks, then 13% is a stress case, not a forecast, and I'm not claiming it's coming. The trim is variance control on an event we can't verify. That's why the proceeds sit in cash and why the 12% to 17% rebuy is optionality, not a return we've banked.

The time stop changes the picture, so here is how. If the print lands in the Oct 27-29 range, five sessions before it is around Oct 20 to 22, about a week away. So the 55.2 limit has roughly five sessions to fill, not nine, and the final backstop sits only a few sessions after that. The plan is mostly a schedule now. On almost every path we're about half sold within a week. What's left open is the last sixth, which gets decided at the time stop with the date, the past reactions, the options chain and the mandate number in hand. I don't think any of us disagrees about anything bigger.

My remaining pushback is that the last decision shouldn't be argued after the numbers arrive. Three things need fixing first.

Write the rules down before anyone looks. The stress gap is the larger of twice the implied move and the worst of the last several print reactions, measured close to close over the print day and the day after, since that's how the 13% was measured. Also put a number on "clearly heavy volume." I'd say 8 million shares, roughly double the 3 to 5 million baseline. That's my judgment, not a tool output, but a number set now can't be bent later. If the lookups come back mixed, whoever reads them first will be tempted to pick the rule that fits their preferred size.

The loss budget should cover the whole rate and housing cluster, not CARR alone. If the book already holds other building products, HVAC or housing-sensitive names, a hot CPI or an oil spike hits them together. A 13% single-name stress then understates the combined loss. In that case the formula can come out below a third, and I'd rather say so now than discover it later.

Read the Q2 release's guide for Q3 and the year today. That's the number Carrier has to meet. Four price-target cuts with no stated reasons and no consensus figure give us direction, not a bar. The guide tells us whether "lowered expectations" is a fact or a feeling. If it's a feeling, the squeeze story rests on less than it appears to.

Neutral's point about the proceeds is right, and it has a second reason. Trane, Johnson Controls and Lennox all report around the same window, so buying them swaps our gap risk for theirs. Hold cash or something broad.

Here is the plan I'd back. Today, confirm the print date from the advisory, the ex-dividend date, the FOMC dates (I'm going from memory on Oct 27-28), the peer calendar, the past print reactions, the options chain, the Q2 guide and the mandate's loss number. Sell a quarter of a standard allocation now, or a third if a peer reports inside the window or the lookups aren't done by tomorrow's close. Rest the next quarter at 55.2 to 55.6, adjusted down about 24 cents if the ex-date falls inside the window. Convert it to market on two closes under about 53.9, on one close under it on 8 million shares or more, or five sessions before the print. Finish on any close under 52.96, two sessions before the print, or ahead of an FOMC decision if one falls in that stretch. Set the final retained size at loss budget over stress gap, capped at half, with a third as the written default. A hard mandate limit overrides it, and conflicts go back to the caller. If the caller is already at or below a third, don't add. If flat, stay flat. Treat 58.47 as a signal to reassess, not a stop. Rebuild small after the print, with the first piece gated on guidance and the GAAP-to-adjusted bridge in the release. I back the Sell, and no short.

Neutral Analyst

Neutral Analyst: I agree with the direction. The Sell is right. But I think you two are fighting over much less than you believe, and each of you is leaning on a weak spot.

Start with how small the gap is. The difference between keeping half and keeping a third is one-sixth of the position. A squeeze of 8% to 10% on that sixth costs about 1.3% to 1.7% of the position. A 9% to 13% gap on that sixth costs about 1.5% to 2.2%. That's roughly one and a half to two percent either way. If a standard allocation were 3% of the book, the half-versus-third decision is worth about six or seven basis points. It's a sizing preference, not a thesis fight.

To the aggressive analyst: your plan says don't wait for permission, but its best path waits for a bounce to 55.2. The 10 EMA and Bollinger middle sit there, so it's real resistance, but the stock can simply not get there. You also say capitulation hasn't shown up, yet September 18 had RSI at 27 on 21 million shares. Either that was a flush and we're retesting it, or it was third-Friday mechanical volume and the flush isn't in. You can't use both readings.

Your squeeze story also looks generous next to the tape. The entire bounce after September 18 was about 4.6% on a closing basis, from 53.88 to 56.37. An 8% to 10% one-day pop is roughly double that. The down-tail has a precedent: the two sessions on July 28 and 29 took the stock from 69.33 to 59.92, about 13.6%, on around 16 million shares each day. That timing matches when Carrier usually reports Q2, but the tools don't name the catalyst, so I'd treat it as likely, not confirmed. Last, ADX of 15.8 describes how the last few weeks traded. It says nothing about the shape of an earnings gap, so it's not a reason to keep half.

To the conservative analyst: your one-third ceiling is as arbitrary as the half. Your argument that a floor is what a gap jumps over proves too much. If support levels are irrelevant to a gap, the logical size is zero, not a third. Your line that a missed squeeze is opportunity cost, not lost capital, depends on the mandate. If this book is benchmarked and the stock squeezes, that's a real relative loss.

I also don't think the Viessmann overhang is a pre-print problem. A director-affiliated holder is normally in a blackout window right before earnings, and his two prior blocks came several weeks after earnings. I can't confirm the company's window or any trading plan, but the supply risk looks bigger after the print than before it. That argues for staging the rebuild, which the trader's plan already does, not for selling more now.

I'll give you your best point, though. A first tranche now costs under 2% against a 55.2 fill, and that makes the plan less dependent on a bounce. That's cheap insurance.

My version:

  1. Confirm the earnings date today. Carrier already issued the advisory, so the date is in that release. If it's in the usual late-October window, we're about nine to eleven sessions out, and a bounce has to arrive fast to be useful. Everything else keys off that date.
  2. Sell about a quarter of the position in the next day or two, with no price condition. That's smaller than the conservative's third, so more of the position can still catch a bounce fill. If we're at a standard allocation, this already delivers half of the trader's trim.
  3. Rest a limit for another quarter at 55.2 to 55.6. That reaches the trader's roughly 50% target if the bounce comes.
  4. Keep the backstops. Finish at market two sessions before the confirmed date, or immediately on a close below 52.96 on volume.
  5. Decide the final retained size by the mandate, not by the squeeze story. If the book can absorb a 13% gap on what's left, stay near half. If it can't, or if the date can't be confirmed, go to a third.

Two data gaps should shape the sizing. First, someone should pull the options chain. Neither side has the implied earnings move, and it would tell us whether 8% to 10% up and 9% to 13% down are sensible tails. It would also price a put spread, so we'd know whether hedging the retained piece is worth it. Second, both of you lean on the 3.5x leverage figure and the unverifiable $3.31. The leverage figure is backed out of a debt-to-equity ratio and divided by a GAAP-depressed EBITDA, so it could look worse than reality. I'd keep valuation out of the sizing math and let the tape, the event and the mandate decide.

On the rebuild, treat 58.47 as the signal to reassess, not a stop. The 200 SMA at 61.44 and the weekly SuperTrend at 66.98 sit well above it, so any rebuild should come in steps after the print. And no short.

This gets most of the protection the conservative wants, a realistic shot at the better fill the aggressive wants, and it doesn't require anyone to be right about whether the next gap is 8% up or 13% down. Neutral Analyst: We've converged more than the tone suggests, so here is what's actually left. Quarter versus third on the unconditional sale is about 0.15% of the position against a 55.2 fill. Half versus a third retained is about 1.5% to 2% either way, on a sixth of the position. And the inputs we're arguing over (the tails, the bar, the mandate) are things nobody here has measured. So I'd stop trying to win a default and ask what has to be decided today.

Aggressive, you keep saying the default stays at half because it's the trader's plan. The trader's own sizing paragraph has both numbers: trim to about half, and cap at about a third if the desk must hold exposure and the mandate can absorb a 13% gap. The plan doesn't settle it. The "bar lowered four times" argument is also weaker than it sounds. Those are four price-target cuts, the reports say no reasons were given, and there's no consensus number on the desk. That's an inference, the same as the conservative's "less bad than feared still gets sold on the guide." Neither belongs in the sizing math. The tracking-error point is real, but only if the book is benchmarked. In an absolute-return book a missed squeeze costs nothing, so you can't defend half without knowing which book this is.

Conservative, I think your trigger change is the weakest part of your revision. A close below 53.88 to 53.94 is about a quarter of an ATR from today's close of 54.24, and today's low of 53.58 already traded through it. That trigger will probably fire within days, which turns the plan into selling the lows on a filter we haven't defined. The 4.6M volume on today's bar may not even be final. The technical report also shows that area was bought in March: a 53.97 close on 3/30, then 55.91 the next day, a 3.6% bounce. That's one instance, but you used one July sell-off as the precedent for the tail, and a single case doesn't make a distribution in either direction. The July catalyst isn't even named in the tools. Your Viessmann point has a gap too. If supply comes weeks after the print, it doesn't meet the one-day squeeze you're worried the retained half captures. It meets the rebuild, which is why the rebuild should be staged. I'll concede that I can't see a pre-arranged selling plan, so check the Form 4 and 13D/G filings. Your peer-print point is the best new argument in your last turn, but nobody has checked the calendar. And the gap between holding 67% and 75% for nine sessions is eight points of position, so it can't carry the weight you put on it.

Both of you are also treating the $3.31 and the bar as unknowable, and they aren't. Q2 is already out, and the July drop looks like its reaction, though that's inferred. The fundamentals tool just doesn't show it. One look at the Q2 release for guidance, plus a consensus number, tells us whether $3.31 is a real adjusted figure. Right now it is unverified, not unverifiable. The same goes for the tails. The 8% to 10% up and 9% to 13% down are one sell-off and a guess. The price history the desk already has will show the last several earnings-day moves, and that's cheaper than the options chain.

My plan, adjusted:

  1. Today: get the date from the advisory and check the peer calendar for Trane, JCI and Lennox. Pull past earnings-day moves, the Q2 guidance and consensus, and the options chain if possible.
  2. First sale: sell a quarter at market with no price condition. Make it a third if a peer reports inside the window, since that's the one scheduled pre-print gap risk we can name.
  3. Second sale: rest a limit for the next quarter at 55.2 to 55.6. I agree the touch is plausible. The stock closed at 55.03 yesterday and has been in that area several times since 9/18.
  4. Graduated triggers: a close below about 53.9 on volume clearly above the 3 to 5M baseline converts the resting limit to market, which puts us at half sold. A close below 52.96 on volume, or two sessions before the confirmed date, whichever comes first, finishes to the final size.
  5. Final retained size: the mandate gives a corridor, not a number. The loss budget divided by the stress gap (13% unless the history and options say otherwise) sets the ceiling, and tracking error sets the floor if the book is benchmarked. Half and a third usually both fit inside that corridor. If the caller can't run the numbers, the fallback is a third.

This also removes the need to decide half versus a third today. Nothing executes at that margin until the limit fills or the backstop fires, and by then the data should be in. 58.47 remains a reassessment signal, not a stop. The rebuild should come in steps after the print, and there's no short. Neutral Analyst: We've converged enough that I think the remaining disagreement is smaller than either of you is treating it, and it comes down to one number.

Conservative's third at a 13% stress gap and Aggressive's half at a 9% stress gap both come to a loss of about 4.3% to 4.5% of a standard allocation. So you aren't disagreeing about risk appetite. You're disagreeing about whether the bad outcome is 9% or 13%. The 13% is the two-session July move, and the 9% is the first session alone. We only have closes, so we can't say how much of either was an overnight gap, and the tools don't name the catalyst. I also have to flag that I called July the Q2 reaction last time and labeled it an inference, and I'd now hold it more loosely. From memory, not from the tools, the July FOMC meeting was the 28th and 29th, the same two days as that drop. If that's right, July may have been partly a macro move. Either way, the same lookup settles it. Pull the price history around the actual Q2 release date and see what the print day did.

That memory cuts forward too. I believe the October FOMC is the 27th and 28th, which would land right on a typical late-October Carrier print. Please check it. Stacked events make the "two sessions before" backstop matter more.

Conservative, you're right that the volume-only trigger is wrong for how this decline has traded. Distribution has come on 3 to 5 million share days, so waiting for double volume waits for a day this stock hasn't needed. I'll take your version: two consecutive closes below about 53.9, or one on clearly heavy volume. Your dividend point makes that safer to run. A 24-cent ex-dividend drop would use up most of the 34 cents between today's close and 53.9, so once someone has the ex-date, every price level in the plan should be adjusted for it. Otherwise a dividend can fire a trigger, or make the 55.2 limit harder to reach, with no information in it.

Where I'd push back is on "the ceiling always wins." A loss limit beats a tracking preference, but a benchmark's active-weight band can be a hard limit too. Whichever is a real constraint in the mandate binds, and if two hard limits conflict, that goes back to the caller. On your 2x-implied-move rule, I think it's reasonable. Under a normal assumption it's roughly a one-in-twenty move, which is my back-of-envelope, and earnings tails are fatter than that. I'd take the larger of that and the worst of the last several reactions, but not a single observation by itself.

On the rebuild, you're right that price can't be the trigger on the day of a gap through every level. But a few sessions later, a new low that holds is information again. So gate the first small tranche on the release content, and let price confirm the later ones.

Aggressive, thank you for retiring the lowered-bar argument and the 13% anchor. The macro squeeze mechanism is real, but it's two-sided. Hot inflation, rising global yields and a hike priced at 78% sit in the same report, so I wouldn't count it as upside beyond what's already in the range. The case for keeping some exposure is that nobody can tell which way the surprise breaks, and that's enough.

Two things nobody has said. First, the homework list has grown past what the stakes justify. Three lookups change the action: the confirmed date, the past print reactions plus the implied move, and the mandate number. The ex-dividend date is a fourth, because it's mechanical. The peer calendar only matters for the size of the first sale. The Form 4 check and the CPI date are tuning.

Second, a diversification point. Don't send the proceeds into Trane, Johnson Controls or another rate-sensitive building name before the print. That keeps the same housing, rates and peer-print exposure we're trying to cut, and it adds the peer-print gap risk Conservative raised. Park the proceeds in cash or something broad until the rebuild.

Here is my plan. Today, confirm the date, the ex-dividend date and the peer calendar, and pull the past print reactions and the implied move. Sell a quarter at market now, or a third if a peer reports in the window or the date can't be confirmed. Rest a limit for another quarter at 55.2 to 55.6, adjusted for the dividend. Convert it to market on two closes below about 53.9, or one on roughly double-baseline volume. Finish on a close below 52.96 or two sessions before the confirmed print, whichever is first. In most paths that gets us to about half sold within days, and only the final backstop separates half from a third. So we don't need to settle that today. Size the final piece off the loss budget divided by the stress gap, with a third as the written default if nobody runs the division. Treat 58.47 as a signal to reassess, rebuild in steps after the print, and don't short.

This protects against a gap on most of the position without requiring anyone to be right about 8% up versus 13% down. I back the Sell. Neutral Analyst: We're down to a few lookups and one real hole in the plan, so I'll skip relitigating third versus half and spend the time there.

First, you two agree on more than the tone suggests. Conservative says 13% stands until the history shows otherwise, and that a third is the written default. The trader's own plan already ties the third to absorbing a 13% gap, so those are the same rule. Aggressive's half rests on a 9% input. Same loss budget, different stress gap. If nobody produces the numbers, it's a third. If someone does, the formula decides. There's nothing left to win there.

Conservative, you're right about July, and it corrects something I said. I suggested the move might be partly the Fed, but the biggest drop, about 8.9%, came on the 28th, before any decision, and the 29th added another 5% or so. Carrier has historically reported in late July, so the 28th is a plausible Q2 date. That's memory, and the tools don't name the catalyst. One lookup settles it: what did CARR do on the actual Q2 release day? What I'd take from it is that the first session, roughly 9%, is the part nobody can manage, while the second session at least gives you a chance to act. So 13% is a fair stress case but a harsh baseline. Test the formula at both numbers and let the mandate pick.

I'd push on a pattern in your answers, though. Every unknown resolves toward the smaller number. An unconfirmed date means a third, an unchecked peer calendar means a third, an unknown stress gap means 13%, and an unknown mandate means a third. Each is defensible alone, but stacked they make a third the answer whatever the data says. A default is a fallback for when a lookup doesn't happen, and these lookups take minutes. The plan should force them, not let defaults stand in for them.

Your quiet-path point is the best hole anyone has found, and I was too glib saying most paths reach half sold within days. If CARR drifts between 53.9 and 55.1, neither the limit nor the conversion fires, and we hold two-thirds or more until the date backstop. The fix is a time stop. If the limit hasn't filled about five sessions before the confirmed print, it converts to market. Five is my judgment. It costs a few tenths of a percent of the position. In every path we'd be roughly half sold by then, with only the last sixth waiting on the final backstop. That is also the point where half versus a third gets decided, with the date, past reactions, options chain and mandate number in hand.

Aggressive, two things. You keep saying our edge is in the tape, and I'd soften that. The technical report's net read is bearish to neutral with no reversal signal, ADX is under 20, and no Z-score is at an extreme. The tape is a reason not to be the marginal buyer and to sell into strength, but it says nothing about which way a gap breaks. The case for the trim is event risk against inputs nobody can verify: the $3.31, the Q2 numbers and the date. That is why it's a trim and not a short. Second, your 43% example is fine as arithmetic, but a stress gap that is a guess and a mandate number nobody has can't support that precision. I'd round to a third or a half.

We've all been assuming the percentages are against a standard allocation, not against what the caller holds. If you're overweight, the first sale is bigger than a quarter. If you're already at or below a third, there's nothing to sell, so just don't add. If you're flat, stay flat, don't short, and don't buy into the print.

Here is the plan I'd hand over. Today, confirm the print date from the advisory, because everything keys off it. If it can't be confirmed, work to the earliest plausible late-October date. Also pull the ex-dividend date, which may fall after the print, in which case the 24-cent adjustment is moot. Then get the peer calendar, past earnings-day moves including that July session, the options chain, and the mandate's loss number and any benchmark band.

Sell a quarter of a standard allocation at market now, or a third if a peer reports inside the window or the lookups aren't done by tomorrow's close. Rest a limit for the next quarter at 55.2 to 55.6. Convert it to market on two closes under about 53.9, one close on clearly heavy volume, or five sessions before the print, whichever comes first. Finish on any close under 52.96, or two sessions before the print. If an FOMC decision falls in that last stretch, finish ahead of it. I believe October 27-28 is the meeting, but that's memory, so check it.

Retained size is the loss budget divided by the stress gap, capped at half, with a third as the default if nobody runs it. A hard mandate limit overrides, and conflicts go back to the caller. Hold the proceeds in cash or something broad, not Trane or other rate-sensitive building names. 58.47 is a reassessment signal, not a stop. Rebuild small after the print, gated first on guidance and the GAAP-to-adjusted bridge in the release, with price and the 10-Q confirming later tranches.

The live disagreement is worth a percent or two of a single position either way. What matters is selling a real piece before the print, on a confirmed date, instead of reacting afterward. I back the Sell on CARR. Neutral Analyst: We've converged enough that I'll skip third versus half. Nothing we've said justifies spending more words on a gap worth about 2% of a position at one end and about 1.7% at the other. The formula decides it, and what's left is whether the formula and its inputs are airtight.

Conservative, you said the two errors aren't the same size, and I'd trim that. By your own numbers, a 13% gap on the extra sixth costs about 2.2% of the position, and an 8% to 10% squeeze on that sixth costs about 1.3% to 1.7%. That justifies a tilt toward the smaller number as a fallback, which is the written third. It doesn't justify "no repair" language. Your rules-first point is right, but one rule is still loose. The worst of the last several print reactions gets bigger the more history you pull, so the lookback is a free parameter. Fix it now. I'd say the last eight prints, which is my judgment, and I'd take your 8 million shares for heavy volume as written.

I agree the loss budget should cover the whole rate and housing cluster, but I'd split it in two. The print is CARR-specific event risk, while hot CPI and oil are shared macro risk. CARR carries the event piece, and the cluster carries the macro piece. If the cluster check says the book is too heavy, the caller decides which names to cut. That isn't a reason to push CARR below a third on a thesis we haven't made. If the formula lands under a third, it goes back to the caller, same as a conflict between hard limits.

Aggressive, you say the plan reaches about half sold on every path. That holds only if there's slack in the calendar. If the advisory shows a date inside five sessions, the limit leg is moot and the schedule collapses to selling now. Unless the date is that close, the limit has about four to six sessions from today to fill, not nine. Also, "the drift is a warning sign because OBV kept making lows" double counts. OBV falls when the price drifts down on baseline volume, and the "divergence" is price sitting 0.7% above the September closing low. The tape supports not being the marginal buyer and selling into strength. It doesn't support more than that.

Conservative, your plan adjusts the limit down about 24 cents for the dividend but leaves the triggers alone. The 53.9 trigger is only 34 cents from today's close, so once the stock goes ex, a mechanical drop could fire a conversion with no information in it. Shift every price level by the dividend after the ex-date, or confirm the ex-date falls after the print and drop it. The 24 cents is your back-of-envelope from the 1.74% yield, so use the declared amount.

The Q2 guide is the lookup I'd put ahead of the others, because it's the only one that can change what we're afraid of. The fundamentals snapshot looks like it already includes Q2, so the release exists. If full-year adjusted EPS guidance is near the $3.31 behind the forward multiple, the trader's "unverifiable" premise goes away and the case rests on event variance and the tape. If it's well below, the valuation leg gets worse. Neither result belongs in the sizing formula, because I don't want valuation back in it. But it tells us whether the sentence in the trade note is still true, and it gates the first rebuild tranche. One verified number also doesn't remove the print, so the Sell survives either answer.

Nobody has said what "58.47 is a signal to reassess" actually does. Let me define it. A close above it before the print reverses no sale and permits no add. It reopens only the final retained size through the formula. We'd probably already be about half sold at 55.2 to 55.6 by then.

So the plan I'd hand over is this. Today, pull the print date from the advisory, the Q2 guide, the declared dividend and ex-date, the peer calendar, eight prints of reactions, the options chain, the FOMC dates (October 27 to 28 is my memory) and the mandate's loss number and any benchmark band. Anything not done by tomorrow's close falls to a third with no extension. Sell a quarter of a standard allocation now, or a third if a peer reports in the window or the lookups slip. Rest the next quarter at 55.2 to 55.6. Convert it to market on two closes below about 53.9, one close below it on 8 million shares or more, or five sessions before the print. Finish on any close below 52.96, two sessions before the print, or ahead of an FOMC decision that falls in that stretch. Shift all of those levels down by the dividend once the stock goes ex.

Retained size is the loss budget divided by the stress gap, with the stress gap defined as the larger of twice the implied move and the worst of the last eight reactions. It's capped at half, with a third as the written default, and a hard mandate limit overrides it. If the caller is at or below a third, don't add. If flat, stay flat. Keep the proceeds in cash or something broad, not Trane, Johnson Controls or Lennox. Rebuild small after the print, gated first on guidance and the GAAP-to-adjusted bridge, with price and the 10-Q confirming the rest. No short, because we have no edge on the print itself.

What matters is getting a real piece sold on a confirmed date before the print instead of reacting after it. I back the Sell on CARR.

V. Portfolio Manager Decision

Portfolio Manager

Rating: Underweight

Executive Summary: Underweight CARR into the unconfirmed late-October Q3 print, sized against a standard allocation. Sell a quarter at market now, or a third if a peer reports inside the window or today's lookups are not done by tomorrow's close; rest the next quarter at 55.2-55.6, convert it to market on two closes below about 53.9, one close below it on 8M+ shares, or five sessions before the print, and finish on any close below 52.96, two sessions before the print, or ahead of any FOMC decision in that stretch. Keep a retained size equal to your loss budget divided by the stress gap (13% placeholder), capped at half of standard with one-third as the written default; if you already hold a third or less, don't add, if flat stay flat, and don't short, because price stops cannot protect an earnings gap and size is the only risk control. Rebuild after the print through the CLEAN/MIDDLE/CUT buckets over a 1-2 month horizon, with a $51.40 target.

Investment Thesis: WHY UNDERWEIGHT, NOT SELL OR HOLD: All three risk analysts and the trader backed reducing exposure. None argued for a full exit or a short. The trader's 'Sell' label describes a trim to about half, which is Underweight on this scale. The bear case wins, but modestly, as the Research Manager found. (1) The valuation case rests on $3.31 of forward EPS (16.4x) that nobody could verify. TTM GAAP EPS is $1.38 and FY25 GAAP was $1.72. Q1'26 operating income fell about 59% ($629M to $259M) on revenue up 2.4%. Q4'25 operating margin was about 2% (derived), and inferred Q2'26 EPS of about $0.53 was still below $0.68 a year earlier. (2) Every signal that does not depend on the forecast leans the same way. All three SuperTrends are DOWN (stops at 58.47 daily, 66.98 weekly, 75.97 monthly). The close of 54.24 is below the 10 EMA (55.21), 50 SMA (58.08) and 200 SMA (61.44). Closing highs stepped down from 69.33 to 56.37 and closing lows from 59.92 to 53.88. OBV is at a window low of -93.56M versus -81.9M at the lower 9/18 close. RSI is 37.69 and has not reached 50 in 30 days. The MACD histogram has fallen four straight sessions to 0.162. The macro backdrop pressures a 1.29-beta, rate-sensitive name with a current ratio near 1.0 and $1.4B of cash: 78% odds of a December hike, 97% odds of no 2026 cuts, and oil near $103. (3) The event risk is lopsided in practice. A -9% to -13% gap (about 47.2-49.4) would land below the 52-week low (50.24) and the January low (49.67), skipping every level a stop could use. The tape has a precedent: 7/28-29 took the stock from 69.33 to 59.92 (-13.6%), with about 8.9% on the first session, before any Fed decision. The best rally off the September low was only +4.6% on closes. Not Sell, because: ADX of 15.79 says range-bound; no Z-score is at -2 and no TD-9 count signals exhaustion; the CEO bought at $52.62 and FY25 FCF was about $2.1B; Viessmann supply likely comes after the blackout; and a 'less bad' print could squeeze a stock 28% off its high. The tape argues against being the marginal buyer, but gives no edge on which way the print breaks. Not Hold, because an unverifiable binary event with no options data on the desk leaves size as the only control. WEIGHING THE DEBATE: The Conservative won four points: the arithmetic (in an 8-10% squeeze the sold half costs 3-4% of the position, not 3%), the quiet-path hole (a 53.9-55.1 drift triggers nothing), the volume issue (distribution here has come on 3-5M-share days, so a heavy-volume-only trigger would wait for a day this decline has not needed), and fixing the rules before the data arrives. The Aggressive won three: a preference for the smaller position in a tie depends on the mandate, lookups need a deadline rather than defaults that only ever shrink the position, and the first rebuild tranche should be gated on the release, not the 10-Q. The Neutral supplied the framing that settled it. A third at a 13% stress gap and a half at about 9% both cost roughly 4.3-4.5% of a standard allocation, so the dispute is the stress-gap input, not risk appetite. The Neutral also contributed the five-session time stop, shifting levels for the dividend, a fixed eight-print lookback, a clear definition of what a close above 58.47 means, and keeping proceeds out of Trane, JCI and Lennox. EXECUTION: Complete these by tomorrow's close; anything left undone defaults the retained size to one-third: the print date from the advisory; the Q2 guide (full-year adjusted EPS versus $3.31); the declared dividend and ex-date (about $0.24 estimated); the peer calendar; the last eight print reactions (close-to-close over the print day and the next day); the options-implied move; the FOMC dates (Oct 27-28 is unverified memory); and the mandate's loss budget and benchmark band. The loss budget should cover all building, HVAC and housing names held. Stress gap = the larger of twice the implied move and the worst of the last eight reactions. A hard mandate limit overrides the formula; if two hard limits conflict, the caller decides. Shift all price levels down by the declared dividend once the stock trades ex. Hold proceeds in cash or broad exposure. POST-PRINT: CLEAN means an itemized bridge of about $1.10-1.50 a share, guidance near $3.3 with the fiscal year stated, and Q3 operating margin at or above about 10%. Then rebuild toward a full allocation: a small first tranche gated on the release, the rest on a daily close above 58.47 with an OBV higher low. Upgrade to Overweight if guidance is raised, and take partial profits at 61-62. MIDDLE means EPS reset to about $3.00 or margin of 9.7-10%: hold the reduced size with no adds. CUT means no bridge, margin under 10%, or guidance well under $3.00: exit the remainder; a close below 49.67 confirms the thesis break. A new Viessmann block delays re-entry. WHAT CHANGES THE CALL BEFORE THE PRINT: A Q2 guide that verifies about $3.31 removes the unverifiable premise but not the event risk, so the trim stands. A close above 58.47 reverses no sale and permits no add; it only reopens the retained-size formula. A peer print or FOMC decision inside the window speeds up the schedule. PRICE TARGET $51.40: The reports do not support a reliable valuation objective. The $3.31 is unverified, and the only sell-side target cited (Goldman's $61, cut from $85 to $74 to $61) is a single, repeatedly lowered figure with no consensus. So I use the technical objective: the support zone after 52.96 in the report's bearish scenario, the 2025-12-09/12-17 lows at 51.34-51.43. That gives 51.40, or -5.2% from 54.24 (51.40/54.24 - 1). Cross-check: at the debate's roughly 35% odds of an EPS cut, expected EPS = 0.35 x $3.00 + 0.65 x $3.31 = $3.20. At 16.4x that is about $52.5, and $51.40 implies about 16.1x, a modest de-rating consistent with 78% December hike odds. The outcome range is wide: the CUT tail is about 47.2-49.4, and a CLEAN print could retest the 200 SMA at 61.44. Confidence is medium for the decision, because the analysts converged strongly on reducing exposure. It is low for the target, because the earnings date, Q2 statements, the basis of the $3.31, options data and the mandate are all missing.

Current Price: 54.24

Price Target: 51.4

Confidence: Medium

Time Horizon: 1-2 months